{
 "metadata": {
  "name": "",
  "signature": "sha256:3f855a33ad314656fdc82f81e25a3d67feb68237fa44ff92aab8c69815bf5b4b"
 },
 "nbformat": 3,
 "nbformat_minor": 0,
 "worksheets": [
  {
   "cells": [
    {
     "cell_type": "heading",
     "level": 1,
     "metadata": {},
     "source": [
      "Immune Response of P. hel "
     ]
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "This notebook accompanies the manuscript xxx "
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "cd data"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "/Users/sr320/Dropbox/Steven/eimd/paper/data\n"
       ]
      }
     ],
     "prompt_number": 4
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!head Phel_transcriptome_clc.fa"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        ">Phel_clc_contig_1\r\n",
        "CAAATATATGAACGGTTGATTGTCAACGATTAGTACATGTTTTCATTGTTCCCCACGCCC\r\n",
        "GCCCCCCCCCACTCAAACATTTAAAGTGTGAAATATTATTTATCCACAAATTTCCTTAAA\r\n",
        "CCTGCAAACTTGTCTGCTGTCTCTTATTGGAAGTTATGAAAAAGAACAACGGGTTTTCTT\r\n",
        "TAAAGGGTCTGCGTGCGATTTTCAACCTTTTGAGTAATAGCAGTTATTTTGATAACCGAT\r\n",
        "TTTTTTCAAAGCTCAACAGCTTTTTAAAATAAGGAATCCTATAATGGCCAAACGAATACT\r\n",
        "ATAAAAATAAGGGTTCTCTTAATTGTATAAAACGTATAATTTTATCAATTTTGGGACCGT\r\n",
        "GTAATTTTTTAAAGACCACAAGAATGTTACATACAACAAATAGACGAAACTCGTAGCTTT\r\n",
        "GGAAACTACGTCATGGGCGTTTGGTCAAAAGCTGGAGAGAAAGAGAGGTGGGGTGCCAGA\r\n",
        "CTTAAGTAGTCACGTGATCTGACCAACGCACATCGGAAGCTCGATCGGATGAAATCTTCT\r\n"
       ]
      }
     ],
     "prompt_number": 5
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!perl ../scripts/count_fasta.pl -i 10000 Phel_transcriptome_clc.fa"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\r\n",
        "0:9999 \t30486\r\n",
        "10000:19999 \t58\r\n",
        "20000:29999 \t11\r\n",
        "30000:39999 \t9\r\n",
        "40000:49999 \t7\r\n",
        "50000:59999 \t3\r\n",
        "60000:69999 \t2\r\n",
        "70000:79999 \t1\r\n",
        "80000:89999 \t0\r\n",
        "90000:99999 \t0\r\n",
        "100000:109999 \t1\r\n",
        "\r\n",
        "Total length of sequence:\t43945151 bp\r\n",
        "Total number of sequences:\t30578\r\n",
        "N25 stats:\t\t\t25% of total sequence length is contained in the 1930 sequences >= 3393 bp\r\n",
        "N50 stats:\t\t\t50% of total sequence length is contained in the 6425 sequences >= 1848 bp\r\n",
        "N75 stats:\t\t\t75% of total sequence length is contained in the 14670 sequences >= 977 bp\r\n",
        "Total GC count:\t\t\t18236282 bp\r\n",
        "GC %:\t\t\t\t41.50 %\r\n",
        "\r\n"
       ]
      }
     ],
     "prompt_number": 10
    },
    {
     "cell_type": "heading",
     "level": 1,
     "metadata": {},
     "source": [
      "Annotation"
     ]
    },
    {
     "cell_type": "heading",
     "level": 3,
     "metadata": {},
     "source": [
      "UniProtKB/Swiss_Prot"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "blastx \\\n",
      "-query Phel_transcriptome_clc.fa \\\n",
      "#-db /Volumes/web/whale/blast/db/uniprot_sprot \\\n",
      "-out Phel_uniprot_sprot.tab \\\n",
      "-evalue 1E-05 \\\n",
      "-max_target_seqs 1 \\\n",
      "-max_hsps 1 \\\n",
      "-outfmt 6 \\\n",
      "#-num_threads 16"
     ],
     "language": "python",
     "metadata": {},
     "outputs": []
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!head -2 Phel_uniprot_sprot.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_4\tsp|P25001|COX1_PISOC\t88.39\t517\t48\t1\t7061\t5547\t1\t517\t0.0\t  749\r\n",
        "Phel_clc_contig_5\tsp|P20097|SAP_CAVPO\t35.90\t78\t47\t2\t393\t617\t3\t80\t6e-08\t56.6\r\n"
       ]
      }
     ],
     "prompt_number": 41
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!wc -l Phel_uniprot_sprot.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "   11386 Phel_uniprot_sprot.tab\r\n"
       ]
      }
     ],
     "prompt_number": 12
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!tr '|' \"\\t\" <Phel_uniprot_sprot.tab> Phel_uniprot_sprot_sq.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 29
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!head -2 Phel_uniprot_sprot_sq.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_4\tsp\tP25001\tCOX1_PISOC\t88.39\t517\t48\t1\t7061\t5547\t1\t517\t0.0\t  749\r\n",
        "Phel_clc_contig_5\tsp\tP20097\tSAP_CAVPO\t35.90\t78\t47\t2\t393\t617\t3\t80\t6e-08\t56.6\r\n"
       ]
      }
     ],
     "prompt_number": 31
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "#sqlshare python tools location\n",
      "sst=\"/Users/sr320/sqlshare-pythonclient/tools/\""
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 34
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!python {sst}singleupload.py Phel_uniprot_sprot_sq.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "processing chunk line 0 to 11386 (0.0107078552246 s elapsed)\r\n",
        "pushing Phel_uniprot_sprot_sq.tab...\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "parsing C4571FE1...\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "finished Phel_uniprot_sprot_sq.tab\r\n"
       ]
      }
     ],
     "prompt_number": 38
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!python {sst}fetchdata.py -s \"SELECT * FROM [sr320@washington.edu].[Phel_uniprot_sprot_sq.tab]phel left join [sr320@washington.edu].[uniprot-reviewed_wGO_010714]des on phel.Column3=des.Entry\" -f tsv -o Phel_uniprot_info.tab\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 39
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!head -2 Phel_uniprot_info.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Column1\tColumn2\tColumn3\tColumn4\tColumn5\tColumn6\tColumn7\tColumn8\tColumn9\tColumn10\tColumn11\tColumn12\tColumn13\tColumn14\tEntry\tEntry name\tGene ontology IDs\tInteracts with\tCross-reference (GO)\tGene ontology (GO)\tStatus\tInterPro\tPathway\tProtein names\tGene names\tOrganism\tLength\r",
        "\r\n",
        "Phel_clc_contig_100\tsp\tQ16513\tPKN2_HUMAN\t81.33\t332\t61\t1\t7935\t6940\t653\t983\t5E-162\t537\tQ16513\tPKN2_HUMAN\tGO:0005524; GO:0043297; GO:0043296; GO:0006915; GO:0007155; GO:0007049; GO:0051301; GO:0032154; GO:0005737; GO:0005856; GO:0010631; GO:0042826; GO:0030027; GO:0016020; GO:0030496; GO:0005634; GO:0032467; GO:0045931; GO:0004697; GO:0004674; GO:2000145; GO:0006355; GO:0007165; GO:0006351\tQ15118\t\tATP binding; apical junction assembly; apical junction complex; apoptotic process; cell adhesion; cell cycle; cell division; cleavage furrow; cytoplasm; cytoskeleton; epithelial cell migration; histone deacetylase binding; lamellipodium; membrane; midbody; nucleus; positive regulation of cytokinesis; positive regulation of mitotic cell cycle; protein kinase C activity; protein serine/threonine kinase activity; regulation of cell motility; regulation of transcription, DNA-dependent; signal transduction; transcription, DNA-dependent\treviewed\tIPR000961; IPR000008; IPR011072; IPR011009; IPR017892; IPR000719; IPR017441; IPR002290; IPR008271;\t\tSerine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)\tPKN2 PRK2 PRKCL2\tHomo sapiens (Human)\t984\r",
        "\r\n"
       ]
      }
     ],
     "prompt_number": 64
    },
    {
     "cell_type": "heading",
     "level": 4,
     "metadata": {},
     "source": [
      "Quick-Find"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "!fgrep -wi --color \"interleukin\" Phel_uniprot_info.tab"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_10058\tsp\tP20749\tBCL3_HUMAN\t46.15\t247\t122\t5\t44\t775\t121\t359\t6E-58\t204\tP20749\tBCL3_HUMAN\tGO:0032996; GO:0033257; GO:0003677; GO:0030330; GO:0007249; GO:0042088; GO:0045064; GO:0019730; GO:0005737; GO:0042742; GO:0042832; GO:0030198; GO:0002268; GO:0002467; GO:0002455; GO:0042771; GO:0051457; GO:0002315; GO:0043066; GO:0045415; GO:0045892; GO:0042536; GO:0005634; GO:0048471; GO:0032729; GO:0045082; GO:0045944; GO:0045893; GO:0045727; GO:0030674; GO:0000060; GO:0051101; GO:0042345; GO:0010225; GO:0009615; GO:0003700; GO:0048536; GO:0006351\tO95999; P56545; P06239\t\tBcl3-Bcl10 complex; Bcl3/NF-kappaB2 complex; DNA binding; DNA damage response, signal transduction by p53 class mediator; I-kappaB kinase/NF-kappaB cascade; T-helper 1 type immune response; T-helper 2 cell differentiation; antimicrobial humoral response; cytoplasm; defense response to bacterium; defense response to protozoan; extracellular matrix organization; follicular dendritic cell differentiation; germinal center formation; humoral immune response mediated by circulating immunoglobulin; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; maintenance of protein location in nucleus; marginal zone B cell differentiation; negative regulation of apoptotic process; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 biosynthetic process; negative regulation of transcription, DNA-dependent; negative regulation of tumor necrosis factor biosynthetic process; nucleus; perinuclear region of cytoplasm; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; positive regulation of translation; protein binding, bridging; protein import into nucleus, translocation; regulation of DNA binding; regulation of NF-kappaB import into nucleus; response to UV-C; response to virus; sequence-specific DNA binding transcription factor activity; spleen development; transcription, DNA-dependent\treviewed\tIPR002110; IPR020683;\t\tB-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3)\tBCL3 BCL4 D19S37\tHomo sapiens (Human)\t454\r",
        "\r\n",
        "Phel_clc_contig_10324\tsp\tQ3ZCC3\tTRAF6_BOVIN\t65.45\t55\t19\t0\t166\t2\t41\t95\t6E-16\t79.7\tQ3ZCC3\tTRAF6_BOVIN\tGO:0035631; GO:0007249; GO:0050852; GO:0042088; GO:0007250; GO:0019886; GO:0045453; GO:0005938; GO:0048468; GO:0005829; GO:0070498; GO:0009898; GO:0005811; GO:0043011; GO:0000122; GO:0001843; GO:0031965; GO:0042475; GO:0001503; GO:0030316; GO:0048471; GO:0043123; GO:0043507; GO:0051092; GO:0002726; GO:0042102; GO:0045084; GO:0032743; GO:0045410; GO:0031666; GO:0045672; GO:0045944; GO:2000679; GO:0070534; GO:0051865; GO:0042981; GO:0051023; GO:0004871; GO:0004842; GO:0008270\t\t\tCD40 receptor complex; I-kappaB kinase/NF-kappaB cascade; T cell receptor signaling pathway; T-helper 1 type immune response; activation of NF-kappaB-inducing kinase activity; antigen processing and presentation of exogenous peptide antigen via MHC class II; bone resorption; cell cortex; cell development; cytosol; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1-mediated signaling pathway; internal side of plasma membrane; lipid particle; myeloid dendritic cell differentiation; negative regulation of transcription from RNA polymerase II promoter; neural tube closure; nuclear membrane; odontogenesis of dentin-containing tooth; ossification; osteoclast differentiation; perinuclear region of cytoplasm; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JUN kinase activity; positive regulation of NF-kappaB transcription factor activity; positive regulation of T cell cytokine production; positive regulation of T cell proliferation; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 biosynthetic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 biosynthetic process; positive regulation of lipopolysaccharide-mediated signaling pathway; positive regulation of osteoclast differentiation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription regulatory region DNA binding; protein K63-linked ubiquitination; protein autoubiquitination; regulation of apoptotic process; regulation of immunoglobulin secretion; signal transducer activity; ubiquitin-protein ligase activity; zinc ion binding\treviewed\tIPR002083; IPR012227; IPR008974; IPR027139; IPR001841; IPR013083; IPR017907; IPR001293;\tProtein modification; protein ubiquitination.\tTNF receptor-associated factor 6 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF6)\tTRAF6\tBos taurus (Bovine)\t542\r",
        "\r\n",
        "Phel_clc_contig_10614\tsp\tQ8TD23\tZN675_HUMAN\t43.19\t257\t130\t5\t139\t894\t282\t527\t8E-55\t195\tQ8TD23\tZN675_HUMAN\tGO:0003677; GO:0007249; GO:0045453; GO:0019221; GO:0046329; GO:0043508; GO:0032088; GO:2000660; GO:0045671; GO:0000122; GO:2000678; GO:0010804; GO:0005634; GO:0048471; GO:0006351; GO:0008270\tQ9Y4K3\t\tDNA binding; I-kappaB kinase/NF-kappaB cascade; bone resorption; cytokine-mediated signaling pathway; negative regulation of JNK cascade; negative regulation of JUN kinase activity; negative regulation of NF-kappaB transcription factor activity; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1-mediated signaling pathway; negative regulation of osteoclast differentiation; negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription regulatory region DNA binding; negative regulation of tumor necrosis factor-mediated signaling pathway; nucleus; perinuclear region of cytoplasm; transcription, DNA-dependent; zinc ion binding\treviewed\tIPR001909; IPR007087; IPR015880; IPR013087;\t\tZinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)\tZNF675 TIZ\tHomo sapiens (Human)\t568\r",
        "\r\n",
        "Phel_clc_contig_10935\tsp\tQ53B88\tNOD2_HYLLA\t25\t360\t225\t14\t688\t1704\t291\t626\t2E-14\t81.6\tQ53B88\tNOD2_HYLLA\tGO:0005524; GO:0050700; GO:0009986; GO:0002367; GO:0005829; GO:0042742; GO:0016045; GO:0032498; GO:0045087; GO:0032500; GO:0070431; GO:0042834; GO:0005886; GO:0043123; GO:0051092; GO:0050718; GO:0032740; GO:0019901; GO:0042981; GO:0031982\t\t\tATP binding; CARD domain binding; cell surface; cytokine production involved in immune response; cytosol; defense response to bacterium; detection of bacterium; detection of muramyl dipeptide; innate immune response; muramyl dipeptide binding; nucleotide-binding oligomerization domain containing 2 signaling pathway; peptidoglycan binding; plasma membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of NF-kappaB transcription factor activity; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-17 production; protein kinase binding; regulation of apoptotic process; vesicle\treviewed\tIPR001315; IPR011029; IPR001611; IPR007111; IPR027417;\t\tNucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15)\tNOD2 CARD15\tHylobates lar (Common gibbon) (White-handed gibbon)\t1040\r",
        "\r\n",
        "Phel_clc_contig_11006\tsp\tP10809\tCH60_HUMAN\t74.15\t561\t140\t1\t1774\t92\t1\t556\t0\t854\tP10809\tCH60_HUMAN\tGO:0006458; GO:0005524; GO:0016887; GO:0002368; GO:0042100; GO:0003688; GO:0002755; GO:0042110; GO:0006919; GO:0009986; GO:0051131; GO:0005905; GO:0030135; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0001530; GO:0046696; GO:0005743; GO:0005759; GO:0019048; GO:0043066; GO:0005886; GO:0050870; GO:0002842; GO:0043065; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0051604; GO:0042026; GO:0050821; GO:0006986; GO:0030141; GO:0003697; GO:0051082\tP38398; P49789\t\t'de novo' protein folding; ATP binding; ATPase activity; B cell cytokine production; B cell proliferation; DNA replication origin binding; MyD88-dependent toll-like receptor signaling pathway; T cell activation; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; chaperone-mediated protein complex assembly; coated pit; coated vesicle; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide binding; lipopolysaccharide receptor complex; mitochondrial inner membrane; mitochondrial matrix; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; plasma membrane; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interferon-alpha production; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of macrophage activation; protein maturation; protein refolding; protein stabilization; response to unfolded protein; secretory granule; single-stranded DNA binding; unfolded protein binding\treviewed\tIPR018370; IPR001844; IPR002423; IPR027409; IPR027413;\t\t60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)\tHSPD1 HSP60\tHomo sapiens (Human)\t573\r",
        "\r\n",
        "Phel_clc_contig_1130\tsp\tQ1RMT8\tIRAK4_BOVIN\t46.2\t329\t167\t7\t182\t1165\t132\t451\t3E-60\t220\tQ1RMT8\tIRAK4_BOVIN\tGO:0005524; GO:0001816; GO:0019221; GO:0005737; GO:0045087; GO:0000287; GO:0004674\t\t\tATP binding; cytokine production; cytokine-mediated signaling pathway; cytoplasm; innate immune response; magnesium ion binding; protein serine/threonine kinase activity\treviewed\tIPR011029; IPR017428; IPR011009; IPR000719;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)\tIRAK4\tBos taurus (Bovine)\t461\r",
        "\r\n",
        "Phel_clc_contig_11415\tsp\tQ8BZM1\tGLMN_MOUSE\t39.77\t259\t152\t4\t436\t1212\t336\t590\t3E-52\t199\tQ8BZM1\tGLMN_MOUSE\tGO:0031462; GO:0031463; GO:0031464; GO:0005171; GO:0042692; GO:0042130; GO:0001843; GO:0050715; GO:0045086; GO:0042327; GO:0040029; GO:0032434; GO:0055105; GO:0001570\t\t\tCul2-RING ubiquitin ligase complex; Cul3-RING ubiquitin ligase complex; Cul4A-RING ubiquitin ligase complex; hepatocyte growth factor receptor binding; muscle cell differentiation; negative regulation of T cell proliferation; neural tube closure; positive regulation of cytokine secretion; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 biosynthetic process; positive regulation of phosphorylation; regulation of gene expression, epigenetic; regulation of proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase inhibitor activity; vasculogenesis\treviewed\tIPR019516; IPR013877;\t\tGlomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein)\tGlmn Fap48\tMus musculus (Mouse)\t596\r",
        "\r\n",
        "Phel_clc_contig_11525\tsp\tQ4V892\tSIGIR_RAT\t50\t58\t28\t1\t1863\t1693\t148\t205\t3E-07\t57.4\tQ4V892\tSIGIR_RAT\tGO:0006953; GO:0016021; GO:0016020; GO:0045079; GO:0001960; GO:0043433; GO:0007165\t\t\tacute-phase response; integral to membrane; membrane; negative regulation of chemokine biosynthetic process; negative regulation of cytokine-mediated signaling pathway; negative regulation of sequence-specific DNA binding transcription factor activity; signal transduction\treviewed\tIPR007110; IPR013783; IPR003599; IPR015621; IPR000157;\t\tSingle Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/\u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor 8) (TIR8)\tSigirr\tRattus norvegicus (Rat)\t409\r",
        "\r\n",
        "Phel_clc_contig_11936\tsp\tP42229\tSTA5A_HUMAN\t48.98\t294\t133\t5\t5145\t4291\t456\t741\t3E-77\t279\tP42229\tSTA5A_HUMAN\tGO:0006103; GO:0060397; GO:0048541; GO:0000979; GO:0033077; GO:0043029; GO:0000255; GO:0005509; GO:0006101; GO:0006600; GO:0046449; GO:0005829; GO:0046543; GO:0046544; GO:0060742; GO:0006631; GO:0007565; GO:0006549; GO:0007595; GO:0019915; GO:0001553; GO:0061180; GO:0001779; GO:0045647; GO:0033026; GO:0005654; GO:0006107; GO:0018108; GO:0045579; GO:0042104; GO:0045588; GO:0050729; GO:0045086; GO:0060376; GO:0070668; GO:0045931; GO:0040018; GO:0032825; GO:0045954; GO:0045944; GO:0038161; GO:0060740; GO:0030155; GO:0030856; GO:0040014; GO:0019218; GO:0006357; GO:0003700; GO:0004871; GO:0006105; GO:0019530; GO:0006351; GO:0006573\tQ99490-2; P18031\t\t2-oxoglutarate metabolic process; JAK-STAT cascade involved in growth hormone signaling pathway; Peyer's patch development; RNA polymerase II core promoter sequence-specific DNA binding; T cell differentiation in thymus; T cell homeostasis; allantoin metabolic process; calcium ion binding; citrate metabolic process; creatine metabolic process; creatinine metabolic process; cytosol; development of secondary female sexual characteristics; development of secondary male sexual characteristics; epithelial cell differentiation involved in prostate gland development; fatty acid metabolic process; female pregnancy; isoleucine metabolic process; lactation; lipid storage; luteinization; mammary gland epithelium development; natural killer cell differentiation; negative regulation of erythrocyte differentiation; negative regulation of mast cell apoptotic process; nucleoplasm; oxaloacetate metabolic process; peptidyl-tyrosine phosphorylation; positive regulation of B cell differentiation; positive regulation of activated T cell proliferation; positive regulation of gamma-delta T cell differentiation; positive regulation of inflammatory response; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 biosynthetic process; positive regulation of mast cell differentiation; positive regulation of mast cell proliferation; positive regulation of mitotic cell cycle; positive regulation of multicellular organism growth; positive regulation of natural killer cell differentiation; positive regulation of natural killer cell mediated cytotoxicity; positive regulation of transcription from RNA polymerase II promoter; prolactin signaling pathway; prostate gland epithelium morphogenesis; regulation of cell adhesion; regulation of epithelial cell differentiation; regulation of multicellular organism growth; regulation of steroid metabolic process; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; signal transducer activity; succinate metabolic process; taurine metabolic process; transcription, DNA-dependent; valine metabolic process\treviewed\tIPR011992; IPR008967; IPR000980; IPR001217; IPR013800; IPR015988; IPR013801; IPR012345; IPR013799;\t\tSignal transducer and activator of transcription 5A\tSTAT5A STAT5\tHomo sapiens (Human)\t794\r",
        "\r",
        "\r\n",
        "Phel_clc_contig_12084\tsp\tQ8BJQ4\tTCAM2_MOUSE\t30.97\t113\t71\t5\t24\t350\t59\t168\t9E-08\t53.5\tQ8BJQ4\tTCAM2_MOUSE\tGO:0005794; GO:0035669; GO:0071222; GO:0005769; GO:0005783; GO:0006954; GO:0045087; GO:0005149; GO:0045323; GO:0005770; GO:0005543; GO:0071651; GO:0032729; GO:2000494; GO:0032755; GO:0034145; GO:0046982; GO:0043122; GO:0070671\t\t\tGolgi apparatus; TRAM-dependent toll-like receptor 4 signaling pathway; cellular response to lipopolysaccharide; early endosome; endoplasmic reticulum; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor binding; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor complex; late endosome; phospholipid binding; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-18-mediated signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of toll-like receptor 4 signaling pathway; protein heterodimerization activity; regulation of I-kappaB kinase/NF-kappaB cascade; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12\treviewed\tIPR000157;\t\tTIR domain-containing adapter molecule 2 (TICAM-2) (TRIF-related adapter molecule) (Toll/\u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor domain-containing protein)\tTicam2 Tirp Tram\tMus musculus (Mouse)\t232\r",
        "\r\n",
        "Phel_clc_contig_1244\tsp\tP58682\tTLR8_MOUSE\t29.22\t787\t469\t24\t2933\t648\t287\t1010\t5E-52\t203\tP58682\tTLR8_MOUSE\tGO:0003677; GO:0007249; GO:0002755; GO:0071260; GO:0051607; GO:0003725; GO:0006954; GO:0045087; GO:0016021; GO:0045089; GO:0045356; GO:0045359; GO:0045078; GO:0045416; GO:0050707; GO:0003727; GO:0034158\t\t\tDNA binding; I-kappaB kinase/NF-kappaB cascade; MyD88-dependent toll-like receptor signaling pathway; cellular response to mechanical stimulus; defense response to virus; double-stranded RNA binding; inflammatory response; innate immune response; integral to membrane; positive regulation of innate immune response; positive regulation of interferon-alpha biosynthetic process; positive regulation of interferon-beta biosynthetic process; positive regulation of interferon-gamma biosynthetic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 biosynthetic process; regulation of cytokine secretion; single-stranded RNA binding; toll-like receptor 8 signaling pathway\treviewed\tIPR000483; IPR001611; IPR003591; IPR026906; IPR000157; IPR027175;\t\tToll-like receptor 8 (CD antigen CD288)\tTlr8\tMus musculus (Mouse)\t1032\r",
        "\r\n",
        "Phel_clc_contig_12563\tsp\tQ15399\tTLR1_HUMAN\t32.23\t121\t76\t3\t357\t7\t640\t758\t1E-13\t78.6\tQ15399\tTLR1_HUMAN\tGO:0002755; GO:0042088; GO:0035354; GO:0071727; GO:0042496; GO:0042495; GO:0006955; GO:0006954; GO:0045087; GO:0005887; GO:0042116; GO:0030670; GO:0045410; GO:0042535; GO:0046982; GO:0050707; GO:0034150; GO:0004888\t\t\tMyD88-dependent toll-like receptor signaling pathway; T-helper 1 type immune response; Toll-like receptor 1-Toll-like receptor 2 protein complex; cellular response to triacyl bacterial lipopeptide; detection of diacyl bacterial lipopeptide; detection of triacyl bacterial lipopeptide; immune response; inflammatory response; innate immune response; integral to plasma membrane; macrophage activation; phagocytic vesicle membrane; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 biosynthetic process; positive regulation of tumor necrosis factor biosynthetic process; protein heterodimerization activity; regulation of cytokine secretion; toll-like receptor 6 signaling pathway; transmembrane signaling receptor activity\treviewed\tIPR000483; IPR001611; IPR000157; IPR027187; IPR017241;\t\tToll-like receptor 1 (Toll/\u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor-like protein) (TIL) (CD antigen CD281)\tTLR1 KIAA0012\tHomo sapiens (Human)\t786\r",
        "\r\n",
        "Phel_clc_contig_12582\tsp\tQ5E985\tHYAL1_BOVIN\t35.8\t405\t239\t4\t2138\t984\t43\t446\t2E-83\t280\tQ5E985\tHYAL1_BOVIN\tGO:0005975; GO:0051216; GO:0071493; GO:0044344; GO:0071347; GO:0071467; GO:0036120; GO:0071356; GO:0031410; GO:0005615; GO:0036117; GO:0030213; GO:0030214; GO:0050501; GO:0004415; GO:0006954; GO:0005764; GO:0030308; GO:0045766; GO:0045785; GO:0030307; GO:0010634; GO:0050679; GO:1900106; GO:0046677; GO:0000302; GO:0009615; GO:0008134\t\t\tcarbohydrate metabolic process; cartilage development; cellular response to UV-B; cellular response to fibroblast growth factor stimulus; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; cellular response to pH; cellular response to platelet-derived growth factor stimulus; cellular response to tumor necrosis factor; cytoplasmic vesicle; extracellular space; hyaluranon cable; hyaluronan biosynthetic process; hyaluronan catabolic process; hyaluronan synthase activity; hyalurononglucosaminidase activity; inflammatory response; lysosome; negative regulation of cell growth; positive regulation of angiogenesis; positive regulation of cell adhesion; positive regulation of cell growth; positive regulation of epithelial cell migration; positive regulation of epithelial cell proliferation; positive regulation of hyaluranon cable assembly; response to antibiotic; response to reactive oxygen species; response to virus; transcription factor binding\treviewed\tIPR013785; IPR000742; IPR017853; IPR018155;\t\tHyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1)\tHYAL1\tBos taurus (Bovine)\t450\r",
        "\r\n",
        "Phel_clc_contig_12649\tsp\tQ6P8G1\tILF2_XENTR\t65.67\t335\t113\t2\t201\t1202\t24\t357\t4E-161\t477\tQ6P8G1\tILF2_XENTR\tGO:0005524; GO:0003677; GO:0003725; GO:0006955; GO:0005730; GO:0045893; GO:0006351; GO:0016740\t\t\tATP binding; DNA binding; double-stranded RNA binding; immune response; nucleolus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; transferase activity\treviewed\tIPR006116; IPR006561;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K enhancer-binding factor 2 homolog\tilf2 TEgg021l09.1 TEgg033l23.1\tXenopus tropicalis (Western clawed frog) (Silurana tropicalis)\t388\r",
        "\r\n",
        "Phel_clc_contig_12799\tsp\tQ9UJZ1\tSTML2_HUMAN\t61.32\t243\t90\t2\t1071\t1799\t114\t352\t4E-80\t266\tQ9UJZ1\tSTML2_HUMAN\tGO:0035710; GO:0050852; GO:1901612; GO:0006874; GO:0005856; GO:0019897; GO:0032623; GO:0010876; GO:0045121; GO:0042776; GO:0006851; GO:0005743; GO:0005758; GO:0034982; GO:1900210; GO:0090297; GO:0010918; GO:0051259; GO:0005102; GO:1990046\t\t\tCD4-positive, alpha-beta T cell activation; T cell receptor signaling pathway; cardiolipin binding; cellular calcium ion homeostasis; cytoskeleton; extrinsic to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 production; lipid localization; membrane raft; mitochondrial ATP synthesis coupled proton transport; mitochondrial calcium ion transport; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrial protein processing; positive regulation of cardiolipin metabolic process; positive regulation of mitochondrial DNA replication; positive regulation of mitochondrial membrane potential; protein oligomerization; receptor binding; stress-induced mitochon"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "drial fusion\treviewed\tIPR001107; IPR001972;\t\tStomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)\tSTOML2 SLP2 HSPC108\tHomo sapiens (Human)\t356\r",
        "\r\n",
        "Phel_clc_contig_1300\tsp\tQ63369\tNFKB1_RAT\t39.82\t447\t201\t7\t3997\t2672\t52\t435\t6E-70\t250\tQ63369\tNFKB1_RAT\tGO:0005829; GO:0003690; GO:0043066; GO:0001818; GO:0050728; GO:0045083; GO:0045892; GO:0005634; GO:0045944; GO:0043234; GO:0009617; GO:0046688; GO:0006979; GO:0003700; GO:0007165; GO:0000976; GO:0006351\tP47196; Q99N34\t\tcytosol; double-stranded DNA binding; negative regulation of apoptotic process; negative regulation of cytokine production; negative regulation of inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 biosynthetic process; negative regulation of transcription, DNA-dependent; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein complex; response to bacterium; response to copper ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; signal transduction; transcription regulatory region sequence-specific DNA binding; transcription, DNA-dependent\treviewed\tIPR002110; IPR020683; IPR011029; IPR000488;\t\tNuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] (Fragment)\tNfkb1\tRattus norvegicus (Rat)\t522\r",
        "\r\n",
        "Phel_clc_contig_13523\tsp\tB2RX14\tTUT4_MOUSE\t53.2\t438\t191\t7\t1571\t279\t899\t1329\t8E-142\t454\tB2RX14\tTUT4_MOUSE\tGO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270\t\t\tRNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding\treviewed\tIPR002934; IPR002058; IPR001878;\t\tTerminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)\tZcchc11 Kiaa0191 Tut4\tMus musculus (Mouse)\t1644\r",
        "\r\n",
        "Phel_clc_contig_13948\tsp\tQ8BH75\tRNF41_MOUSE\t31.14\t167\t98\t8\t673\t203\t1\t160\t1E-10\t64.3\tQ8BH75\tRNF41_MOUSE\tGO:0005128; GO:0097191; GO:0005135; GO:0030336; GO:0008285; GO:0000209; GO:0031386; GO:0043408; GO:0045619; GO:0045637; GO:0051896; GO:2000377; GO:0004842; GO:0008270\t\t\terythropoietin receptor binding; extrinsic apoptotic signaling pathway; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-3 receptor binding; negative regulation of cell migration; negative regulation of cell proliferation; protein polyubiquitination; protein tag; regulation of MAPK cascade; regulation of lymphocyte differentiation; regulation of myeloid cell differentiation; regulation of protein kinase B signaling cascade; regulation of reactive oxygen species metabolic process; ubiquitin-protein ligase activity; zinc ion binding\treviewed\tIPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010;\tProtein modification; protein ubiquitination.\tE3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41)\tRnf41 Flrf Nrdp1\tMus musculus (Mouse)\t317\r",
        "\r\n",
        "Phel_clc_contig_142\tsp\tA9XE49\tIL17L_CRAGI\t35.64\t101\t61\t2\t1107\t1397\t79\t179\t5E-09\t60.5\tA9XE49\tIL17L_CRAGI\tGO:0005576; GO:0006954\t\t\textracellular region; inflammatory response\treviewed\tIPR010345;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K 17-like protein (CgIL-17)\t\tCrassostrea gigas (Pacific oyster) (Crassostrea angulata)\t200\r",
        "\r\n",
        "Phel_clc_contig_14892\tsp\tQ0V8R5\tIL16_BOVIN\t42.78\t187\t82\t4\t492\t1\t380\t564\t2E-31\t127\tQ0V8R5\tIL16_BOVIN\tGO:0006935; GO:0005737; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0006351\t\t\tchemotaxis; cytoplasm; extracellular space; nucleus; plasma membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent\treviewed\tIPR020450; IPR001478;\t\tPro-\u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-16 [Cleaved into: \u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)]\tIL16\tBos taurus (Bovine)\t627\r",
        "\r\n",
        "Phel_clc_contig_15202\tsp\tQ7T2L7\tI17RD_CHICK\t31.45\t159\t96\t5\t27\t476\t409\t563\t8E-15\t80.9\tQ7T2L7\tI17RD_CHICK\tGO:0016021; GO:0007165\t\t\tintegral to membrane; signal transduction\treviewed\tIPR013568; IPR000157;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-17 receptor D (IL-17 receptor D) (IL-17RD) (Sef homolog) (cSEF)\tIL17RD SEF\tGallus gallus (Chicken)\t741\r",
        "\r\n",
        "Phel_clc_contig_1544\tsp\tQ90593\tGRP78_CHICK\t85.71\t609\t86\t1\t3266\t1443\t24\t632\t0\t959\tQ90593\tGRP78_CHICK\tGO:0005524; GO:0008180; GO:0006983; GO:0006987; GO:0009986; GO:0042149; GO:0071353; GO:0021680; GO:0021589; GO:0034663; GO:0005788; GO:0005793; GO:0030176; GO:0030496; GO:0043066; GO:0030512; GO:0031398; GO:0051603; GO:0043022\tQ8AYS8\t\tATP binding; COP9 signalosome; ER overload response; activation of signaling protein activity involved in unfolded protein response; cell surface; cellular response to glucose starvation; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4; cerebellar Purkinje cell layer development; cerebellum structural organization; endoplasmic reticulum chaperone complex; endoplasmic reticulum lumen; endoplasmic reticulum-Golgi intermediate compartment; integral to endoplasmic reticulum membrane; midbody; negative regulation of apoptotic process; negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of protein ubiquitination; proteolysis involved in cellular protein catabolic process; ribosome binding\treviewed\tIPR018181; IPR013126;\t\t78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP)\tHSPA5 GRP78\tGallus gallus (Chicken)\t652\r",
        "\r\n",
        "Phel_clc_contig_15442\tsp\tQ04861\tNFKB1_CHICK\t55.45\t303\t125\t5\t897\t16\t41\t342\t6E-99\t321\tQ04861\tNFKB1_CHICK\tGO:0002755; GO:0051059; GO:0035419; GO:0007250; GO:0005829; GO:0045087; GO:0001818; GO:0050728; GO:0045083; GO:0045892; GO:0005634; GO:0045944; GO:0043565; GO:0003700; GO:0035681; GO:0034134; GO:0035682; GO:0034138; GO:0034142; GO:0034146; GO:0034154; GO:0006351\t\t\tMyD88-dependent toll-like receptor signaling pathway; NF-kappaB binding; activation of MAPK activity involved in innate immune response; activation of NF-kappaB-inducing kinase activity; cytosol; innate immune response; negative regulation of cytokine production; negative regulation of inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 biosynthetic process; negative regulation of transcription, DNA-dependent; nucleus; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; toll-like receptor 15 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 21 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 7 signaling pathway; transcription, DNA-dependent\treviewed\tIPR002110; IPR020683; IPR011029; IPR000488; IPR013783; IPR014756; IPR002909; IPR000451; IPR008967; IPR011539;\t\tNuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]\tNFKB1\tGallus gallus (Chicken)\t983\r",
        "\r\n",
        "Phel_clc_contig_15805\tsp\tQ645M6\tFADD_BOVIN\t40\t65\t34\t1\t700\t506\t103\t162\t2E-07\t54.3\tQ645M6\tFADD_BOVIN\tGO:0031265; GO:0097202; GO:0071260; GO:0051607; GO:0097191; GO:0045087; GO:0070265; GO:0043123; GO:0043065; GO:2001238; GO:0032757; GO:0045862; GO:0045944; GO:0032760; GO:0060340\t\t\tCD95 death-inducing signaling complex; activation of cysteine-type endopeptidase activity; cellular response to mechanical stimulus; defense response to virus; extrinsic apoptotic signaling pathway; innate immune response; necrotic cell death; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of extrinsic apoptotic signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of tumor necrosis factor production; positive regulation of type I interferon-mediated signaling pathway\treviewed\tIPR011029; IPR000488; IPR001875; IPR016729;\t\tProtein FADD (FAS-associated death domain protein) (FAS-associating death domain-containing protein)\tFADD\tBos taurus (Bovine)\t209\r",
        "\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_17355\tsp\tQ05117\tPPA5_MOUSE\t43.93\t214\t116\t4\t11\t652\t117\t326\t8E-57\t191\tQ05117\tPPA5_MOUSE\tGO:0003993; GO:0060349; GO:0045453; GO:0050830; GO:0008199; GO:0008198; GO:0005764; GO:0050728; GO:0032691; GO:0032695; GO:0045019; GO:0032929; GO:0032720; GO:0034097; GO:0032496\t\t\tacid phosphatase activity; bone morphogenesis; bone resorption; defense response to Gram-positive bacterium; ferric iron binding; ferrous iron binding; lysosome; negative regulation of inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta production; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 production; negative regulation of nitric oxide biosynthetic process; negative regulation of superoxide anion generation; negative regulation of tumor necrosis factor production; response to cytokine stimulus; response to lipopolysaccharide\treviewed\tIPR024927; IPR004843;\t\tTartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase)\tAcp5 T5ap Trap\tMus musculus (Mouse)\t327\r",
        "\r\n",
        "Phel_clc_contig_17521\tsp\tQ96P20\tNALP3_HUMAN\t27.06\t377\t232\t15\t1692\t658\t168\t533\t2E-18\t94.4\tQ96P20\tNALP3_HUMAN\tGO:0005524; GO:0072559; GO:0006919; GO:0071222; GO:0005829; GO:0051607; GO:0009595; GO:0006954; GO:0045087; GO:0050701; GO:0032621; GO:0042347; GO:0032088; GO:0002674; GO:0050713; GO:0035872; GO:0042834; GO:0051092; GO:0043280; GO:0050718; GO:0051259\tQ7Z434; Q9ULZ3\t\tATP binding; NLRP3 inflammasome complex; activation of cysteine-type endopeptidase activity involved in apoptotic process; cellular response to lipopolysaccharide; cytosol; defense response to virus; detection of biotic stimulus; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 secretion; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-18 production; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of acute inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; peptidoglycan binding; positive regulation of NF-kappaB transcription factor activity; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; protein oligomerization\treviewed\tIPR004020; IPR011029; IPR003590; IPR007111; IPR027417;\t\tNACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)\tNLRP3 C1orf7 CIAS1 NALP3 PYPAF1\tHomo sapiens (Human)\t1036\r",
        "\r\n",
        "Phel_clc_contig_17743\tsp\tQ9JM13\tRABX5_MOUSE\t51.38\t290\t136\t3\t1215\t358\t202\t490\t3E-95\t314\tQ9JM13\tRABX5_MOUSE\tGO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270\t\t\tDNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding\treviewed\tIPR003123; IPR013995; IPR002653;\t\tRab5 GDP/GTP exchange factor (Rabex-5)\tRabgef1 Rabex5\tMus musculus (Mouse)\t491\r",
        "\r\n",
        "Phel_clc_contig_1788\tsp\tA5HNF6\tMYD88_CHICK\t45.88\t279\t142\t5\t793\t1611\t17\t292\t6E-69\t241\tA5HNF6\tMYD88_CHICK\tGO:0002755; GO:0035419; GO:0005829; GO:0050830; GO:0016064; GO:0006954; GO:0045087; GO:0031663; GO:0044130; GO:0005634; GO:0005886; GO:0043123; GO:0046330; GO:0042346; GO:0051092; GO:0045080; GO:0032740; GO:0032747; GO:0032755; GO:0050671; GO:0032760; GO:0050727; GO:0002238; GO:0032494; GO:0009615; GO:0035681; GO:0034134; GO:0035682; GO:0034142; GO:0034146; GO:0034154; GO:0045351\t\t\tMyD88-dependent toll-like receptor signaling pathway; activation of MAPK activity involved in innate immune response; cytosol; defense response to Gram-positive bacterium; immunoglobulin mediated immune response; inflammatory response; innate immune response; lipopolysaccharide-mediated signaling pathway; negative regulation of growth of symbiont in host; nucleus; plasma membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of NF-kappaB import into nucleus; positive regulation of NF-kappaB transcription factor activity; positive regulation of chemokine biosynthetic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-17 production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-23 production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of lymphocyte proliferation; positive regulation of tumor necrosis factor production; regulation of inflammatory response; response to molecule of fungal origin; response to peptidoglycan; response to virus; toll-like receptor 15 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 21 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 7 signaling pathway; type I interferon biosynthetic process\treviewed\tIPR011029; IPR000488; IPR017281; IPR000157;\t\tMyeloid differentiation primary response protein MyD88\tMYD88 RCJMB04_14h3\tGallus gallus (Chicken)\t299\r",
        "\r\n",
        "Phel_clc_contig_17886\tsp\tQ645M6\tFADD_BOVIN\t33.33\t90\t58\t1\t300\t31\t103\t190\t3E-07\t52\tQ645M6\tFADD_BOVIN\tGO:0031265; GO:0097202; GO:0071260; GO:0051607; GO:0097191; GO:0045087; GO:0070265; GO:0043123; GO:0043065; GO:2001238; GO:0032757; GO:0045862; GO:0045944; GO:0032760; GO:0060340\t\t\tCD95 death-inducing signaling complex; activation of cysteine-type endopeptidase activity; cellular response to mechanical stimulus; defense response to virus; extrinsic apoptotic signaling pathway; innate immune response; necrotic cell death; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of extrinsic apoptotic signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of tumor necrosis factor production; positive regulation of type I interferon-mediated signaling pathway\treviewed\tIPR011029; IPR000488; IPR001875; IPR016729;\t\tProtein FADD (FAS-associated death domain protein) (FAS-associating death domain-containing protein)\tFADD\tBos taurus (Bovine)\t209\r",
        "\r\n",
        "Phel_clc_contig_18367\tsp\tQ9NPP4\tNLRC4_HUMAN\t27.32\t205\t127\t8\t1\t573\t321\t517\t1E-06\t52.8\tQ9NPP4\tNLRC4_HUMAN\tGO:0005524; GO:0072557; GO:0006919; GO:0002218; GO:0005829; GO:0042742; GO:0016045; GO:0006954; GO:0045087; GO:0050702; GO:0000287; GO:0035872; GO:0051092; GO:0043065; GO:0042803; GO:0051260; GO:0070269\tItself; P29466\t\tATP binding; IPAF inflammasome complex; activation of cysteine-type endopeptidase activity involved in apoptotic process; activation of innate immune response; cytosol; defense response to bacterium; detection of bacterium; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; magnesium ion binding; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; positive regulation of NF-kappaB transcription factor activity; positive regulation of apoptotic process; protein homodimerization activity; protein homooligomerization; pyroptosis\treviewed\tIPR001315; IPR011029; IPR007111; IPR027417;\t\tNLR family CARD domain-containing protein 4 (CARD, LRR, and NACHT-containing protein) (Clan protein) (Caspase recruitment domain-containing protein 12) (Ice protease-activating factor) (Ipaf)\tNLRC4 CARD12 CLAN CLAN1 IPAF UNQ6189/PRO20215\tHomo sapiens (Human)\t1024\r",
        "\r\n",
        "Phel_clc_contig_18451\tsp\tO95477\tABCA1_HUMAN\t48.48\t429\t205\t3\t3\t1256\t1803\t2226\t3E-125\t410\tO95477\tABCA1_HUMAN\tGO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0044255; GO:0071222; GO:0071300; GO:0015485; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0042157; GO:0007040; GO:0045121; GO:0010887; GO:0010745; GO:0002790; GO:0045335; GO:0006911; GO:0005543; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691\tQ13424; Q13884\t\tATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular lipid metabolic process; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol binding; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; intracellular cholesterol transport; lipoprotein metabolic process; lysosome organization; membrane raft; negative regulation of cholesterol storage; negative regulation of macrophage derived foam cell differentiation; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid binding; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport\treviewed\tIPR003593; IPR026082; IPR003439; IPR017871; IPR027417;\t\tATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)\tABCA1 ABC1 CERP\tHomo sapiens (Human)\t2261\r",
        "\r\n",
        "Phel_clc_contig_18903\tsp\tP14902\tI23O1_HUMAN\t44.74\t76\t36\t2\t744\t529\t330\t403\t4E-09\t61.6\tP14902\tI23O1_HUMAN\tGO:0007610; GO:0002534; GO:0005829; GO:0009055; GO:0007565; GO:0020037; GO:0033754; GO:0034276; GO:0046872; GO:0033555; GO:0070233; GO:0046007; GO:0032693; GO:0002666; GO:0043065; GO:0002678; GO:0032735; GO:0002830; GO:0032496; GO:0030485; GO:0032421; GO:0004833; GO:0006569; GO:0019441\t\t\tbehavior; cytokine production involved in inflammatory response; cytosol; electron carrier activity; female pregnancy; heme binding; indoleamine 2,3-dioxygenase activity; kynurenic acid biosynthetic process; metal ion binding; multicellular organismal response to stress; negative regulation of T cell apoptotic process; negative regulation of activated T cell proliferation; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 production; positive regulation of T cell tolerance induction; positive regulation of apoptotic process; positive regulation of chronic inflammatory response; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 production; positive regulation of type 2 immune response; response to lipopolysaccharide; smooth muscle contractile fiber; stereocilium bundle; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process; tryptophan catabolic process to kynurenine\treviewed\tIPR000898;\tAmino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2.\tIndoleamine 2,3-dioxygenase 1 (IDO-1) (EC 1.13.11.52) (Indoleamine-pyrrole 2,3-dioxygenase)\tIDO1 IDO INDO\tHomo sapiens (Human)\t403\r",
        "\r\n",
        "Phel_clc_contig_19152\tsp\tO95477\tABCA1_HUMAN\t78.12\t96\t21\t0\t3\t290\t1037\t1132\t5E-44\t162\tO95477\tABCA1_HUMAN\tGO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0044255; GO:0071222; GO:0071300; GO:0015485; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0042157; GO:0007040; GO:0045121; GO:0010887; GO:0010745; GO:0002790; GO:0045335; GO:0006911; GO:0005543; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691\tQ13424; Q13884\t\tATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular lipid metabolic process; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol binding; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; intracellular cholesterol transport; lipoprotein metabolic process; lysosome organization; membrane raft; negative regulation of cholesterol storage; negative regulation of macrophage derived foam cell differentiation; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid binding; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport\treviewed\tIPR003593; IPR026082; IPR003439; IPR017871; IPR027417;\t\tATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)\tABCA1 ABC1 CERP\tHomo sapiens (Human)\t2261\r",
        "\r\n",
        "Phel_clc_contig_19223\tsp\tQ86W26\tNAL10_HUMAN\t29.44\t180\t103\t6\t223\t726\t164\t331\t1E-12\t70.5\tQ86W26\tNAL10_HUMAN\tGO:0005524; GO:0005737; GO:0050829; GO:0050832; GO:0036336; GO:0019897; GO:0035397; GO:0045087; GO:0002827; GO:2000318; GO:2000778; GO:2000484\t\t\tATP binding; cytoplasm; defense response to Gram-negative bacterium; defense response to fungus; dendritic cell migration; extrinsic to plasma membrane; helper T cell enhancement of adaptive immune response; innate immune response; positive regulation of T-helper 1 type immune response; positive regulation of T-helper 17 type immune response; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 secretion; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 secretion\treviewed\tIPR004020; IPR011029; IPR007111; IPR027417;\t\tNACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)\tNLRP10 NALP10 NOD8 PYNOD\tHomo sapiens (Human)\t655\r",
        "\r\n",
        "Phel_clc_contig_193\tsp\tP51617\tIRAK1_HUMAN\t36.23\t334\t173\t8\t4282\t3377\t201\t526\t2E-51\t199\tP51617\tIRAK1_HUMAN\tGO:0005524; GO:0007254; GO:0002755; GO:0004704; GO:0035666; GO:0000187; GO:0007250; GO:0071456; GO:0005829; GO:0010008; GO:0045087; GO:0045323; GO:0070498; GO:0005811; GO:0031663; GO:0032088; GO:0043066; GO:0048011; GO:0070423; GO:0005634; GO:0043123; GO:0051092; GO:0048661; GO:0045944; GO:0045893; GO:0046777; GO:0042803; GO:0051259; GO:0001959; GO:0032494; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007178; GO:0004842\tQ15306; Q92985; Q96FA3; Q9HAT8; Q13526; P58753; Q86WV6; Q9Y4K3; Q8VCW4; Q5D1E7\t\tATP binding; JNK cascade; MyD88-dependent toll-like receptor signaling pathway; NF-kappaB-inducing kinase activity; TRIF-dependent toll-like receptor signaling pathway; activation of MAPK activity; activation of NF-kappaB-inducing kinase activity; cellular response to hypoxia; cytosol; endosome membrane; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor complex; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1-mediated signaling pathway; lipid particle; lipopolysaccharide-mediated signaling pathway; negative regulation of NF-kappaB transcription factor activity; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleotide-binding oligomerization domain containing signaling pathway; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of NF-kappaB transcription factor activity; positive regulation of smooth muscle cell proliferation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; protein autophosphorylation; protein homodimerization activity; protein oligomerization; regulation of cytokine-mediated signaling pathway; response to peptidoglycan; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transmembrane receptor protein serine/threonine kinase signaling pathway; ubiquitin-protein ligase activity\treviewed\tIPR011029; IPR000488; IPR011009; IPR000719; IPR017441; IPR008271;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1)\tIRAK1 IRAK\tHomo sapiens (Human)\t712\r",
        "\r\n",
        "Phel_clc_contig_19326\tsp\tQ7ZWA3\tRBMX_DANRE\t60\t85\t34\t0\t791\t537\t2\t86\t3E-24\t104\tQ7ZWA3\tRBMX_DANRE\tGO:0008380; GO:0071013; GO:0071347; GO:0003682; GO:0001047; GO:0070062; GO:0003729; GO:0006397; GO:0006509; GO:0007275; GO:0048025; GO:0005719; GO:0000166; GO:0048026; GO:0045944; GO:0051260; GO:0000381; GO:0044530; GO:0006366\t\t\tRNA splicing; catalytic step 2 spliceosome; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; chromatin binding; core promoter binding; extracellular vesicular exosome; mRNA binding; mRNA processing; membrane protein ectodomain proteolysis; multicellular organismal development; negative regulation of mRNA splicing, via spliceosome; nuclear euchromatin; nucleotide binding; positive regulation of mRNA splicing, via spliceosome; positive regulation of transcription from RNA polymerase II promoter; protein homooligomerization; regulation of alternative mRNA splicing, via spliceosome; supraspliceosomal complex; transcription from RNA polymerase II promoter\treviewed\tIPR012677; IPR012604; IPR000504;\t\tRNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G)\trbmx\tDanio rerio (Zebrafish) (Brachydanio rerio)\t379\r",
        "\r\n",
        "Phel_clc_contig_19736\tsp\tQ62862\tMP2K5_RAT\t66.67\t207\t68\t1\t1\t618\t236\t442\t6E-99\t303\tQ62862\tMP2K5_RAT\tGO:0005524; GO:0070375; GO:0004708; GO:0071363; GO:0005829; GO:0016020; GO:0046872; GO:0032088; GO:0090051; GO:2000342; GO:0043154; GO:2001240; GO:0034115; GO:0045415; GO:0060761; GO:0000122; GO:0005634; GO:0018108; GO:0030307; GO:0050679; GO:0045944; GO:0004674; GO:0004713\t\t\tATP binding; ERK5 cascade; MAP kinase kinase activity; cellular response to growth factor stimulus; cytosol; membrane; metal ion binding; negative regulation of NF-kappaB transcription factor activity; negative regulation of cell migration involved in sprouting angiogenesis; negative regulation of chemokine (C-X-C motif) ligand 2 production; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; negative regulation of heterotypic cell-cell adhesion; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 biosynthetic process; negative regulation of response to cytokine stimulus; negative regulation of transcription from RNA polymerase II promoter; nucleus; peptidyl-tyrosine phosphorylation; positive regulation of cell growth; positive regulation of epithelial cell proliferation; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; protein tyrosine kinase activity\treviewed\tIPR011009; IPR000270; IPR000719; IPR017441; IPR002290; IPR008271;\t\tDual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5)\tMap2k5 Mek5 Mkk5 Prkmk5\tRattus norvegicus (Rat)\t448\r",
        "\r\n",
        "Phel_clc_contig_20014\tsp\tO18973\tRABX5_BOVIN\t41.21\t199\t109\t3\t39\t620\t1\t196\t3E-38\t147\tO18973\tRABX5_BOVIN\tGO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270\tQ9UJY5\t\tDNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding\treviewed\tIPR003123; IPR013995; IPR002653;\t\tRab5 GDP/GTP exchange factor (Rabex-5)\tRABGEF1 RABEX5\tBos taurus (Bovine)\t492\r",
        "\r\n",
        "Phel_clc_contig_2029\tsp\tQ28DL4\tTRAF6_XENTR\t36.73\t275\t162\t5\t942\t1739\t264\t535\t4E-40\t159\tQ28DL4\tTRAF6_XENTR\tGO:0050852; GO:0007250; GO:0046849; GO:0048468; GO:0005737; GO:0070498; GO:0009887; GO:0001503; GO:0043123; GO:0043507; GO:0031666; GO:0045672; GO:0070534; GO:0051865; GO:0042981; GO:0004871; GO:0004842; GO:0008270\t\t\tT cell receptor signaling pathway; activation of NF-kappaB-inducing kinase activity; bone remodeling; cell development; cytoplasm; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1-mediated signaling pathway; organ morphogenesis; ossification; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JUN kinase activity; positive regulation of lipopolysaccharide-mediated signaling pathway; positive regulation of osteoclast differentiation; protein K63-linked ubiquitination; protein autoubiquitination; regulation of apoptotic process; signal transducer activity; ubiquitin-protein ligase activity; zinc ion binding\treviewed\tIPR002083; IPR012227; IPR008974; IPR027139; IPR001841; IPR013083; IPR017907; IPR001293;\tProtein modification; protein ubiquitination.\tTNF receptor-associated factor 6 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF6)\ttraf6 TNeu045k15.1\tXenopus tropicalis (Western clawed frog) (Silurana tropicalis)\t558\r",
        "\r\n",
        "Phel_clc_contig_20465\tsp\tQ8BJQ4\tTCAM2_MOUSE\t27.44\t164\t103\t7\t12\t467\t52\t211\t7E-08\t53.9\tQ8BJQ4\tTCAM2_MOUSE\tGO:0005794; GO:0035669; GO:0071222; GO:0005769; GO:0005783; GO:0006954; GO:0045087; GO:0005149; GO:0045323; GO:0005770; GO:0005543; GO:0071651; GO:0032729; GO:2000494; GO:0032755; GO:0034145; GO:0046982; GO:0043122; GO:0070671\t\t\tGolgi apparatus; TRAM-dependent toll-like receptor 4 signaling pathway; cellular response to lipopolysaccharide; early endosome; endoplasmic reticulum; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor binding; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor complex; late endosome; phospholipid binding; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-18-mediated signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of toll-like receptor 4 signaling pathway; protein heterodimerization activity; regulation of I-kappaB kinase/NF-kappaB cascade; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12\treviewed\tIPR000157;\t\tTIR domain-containing adapter molecule 2 (TICAM-2) (TRIF-related adapter molecule) (Toll/\u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor domain-containing protein)\tTicam2 Tirp Tram\tMus musculus (Mouse)\t232\r",
        "\r\n",
        "Phel_clc_contig_2051\tsp\tO13076\tAA2BR_CHICK\t48.68\t302\t120\t8\t2009\t1173\t22\t311\t2E-55\t202\tO13076\tAA2BR_CHICK\tGO:0001609; GO:0007189; GO:0031668; GO:0016021; GO:0005886; GO:0030819; GO:0030828; GO:0032722; GO:0002882; GO:0031284; GO:0032755; GO:0043306; GO:0010575; GO:0060087\t\t\tG-protein coupled adenosine receptor activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; cellular response to extracellular stimulus; integral to membrane; plasma membrane; positive regulation of cAMP biosynthetic process; positive regulation of cGMP biosynthetic process; positive regulation of chemokine production; positive regulation of chronic inflammatory response to non-antigenic stimulus; positive regulation of guanylate cyclase activity; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of mast cell degranulation; positive regulation vascular endothelial growth factor production; relaxation of vascular smooth muscle\treviewed\tIPR001435; IPR001634; IPR000276; IPR017452;\t\tAdenosine receptor A2b (Adenosine receptor 2b)\tADORA2B\tGallus gallus (Chicken)\t340\r",
        "\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_22285\tsp\tP17439\tGLCM_MOUSE\t54.62\t130\t57\t1\t4\t393\t388\t515\t5E-39\t143\tP17439\tGLCM_MOUSE\tGO:0005975; GO:0071356; GO:0046513; GO:0004348; GO:0006680; GO:0043202; GO:0005765; GO:0043407; GO:0032715; GO:0035307; GO:0046512; GO:0023021\tQ14108; O35114\t\tcarbohydrate metabolic process; cellular response to tumor necrosis factor; ceramide biosynthetic process; glucosylceramidase activity; glucosylceramide catabolic process; lysosomal lumen; lysosomal membrane; negative regulation of MAP kinase activity; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of protein dephosphorylation; sphingosine biosynthetic process; termination of signal transduction\treviewed\tIPR013780; IPR001139; IPR013781; IPR017853;\t\tGlucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase)\tGba\tMus musculus (Mouse)\t515\r",
        "\r\n",
        "Phel_clc_contig_22422\tsp\tQ61586\tGPAT1_MOUSE\t32.34\t572\t330\t14\t1968\t316\t286\t821\t7E-84\t287\tQ61586\tGPAT1_MOUSE\tGO:0016024; GO:0006637; GO:0051607; GO:0055089; GO:0006631; GO:0004366; GO:0006650; GO:0016021; GO:0070970; GO:0005743; GO:0005741; GO:0070236; GO:0055091; GO:0005886; GO:0042104; GO:0040018; GO:0050707; GO:0009749; GO:0019432; GO:0006641\t\t\tCDP-diacylglycerol biosynthetic process; acyl-CoA metabolic process; defense response to virus; fatty acid homeostasis; fatty acid metabolic process; glycerol-3-phosphate O-acyltransferase activity; glycerophospholipid metabolic process; integral to membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 secretion; mitochondrial inner membrane; mitochondrial outer membrane; negative regulation of activation-induced cell death of T cells; phospholipid homeostasis; plasma membrane; positive regulation of activated T cell proliferation; positive regulation of multicellular organism growth; regulation of cytokine secretion; response to glucose stimulus; triglyceride biosynthetic process; triglyceride metabolic process\treviewed\tIPR022284; IPR028354; IPR002123;\tPhospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 1/3.\tGlycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) (P90)\tGpam Gpat1\tMus musculus (Mouse)\t827\r",
        "\r\n",
        "Phel_clc_contig_2260\tsp\tP40189\tIL6RB_HUMAN\t27.32\t366\t225\t14\t397\t1449\t31\t370\t1E-19\t99\tP40189\tIL6RB_HUMAN\tGO:0004897; GO:0070110; GO:0030425; GO:0009897; GO:0005576; GO:0005615; GO:0005977; GO:0004921; GO:0045509; GO:0005896; GO:0070102; GO:0048861; GO:0019048; GO:0043066; GO:0070104; GO:0043025; GO:0005900; GO:0038165; GO:0042102; GO:0002675; GO:0002821; GO:0048711; GO:0010613; GO:0045669; GO:0042511; GO:0042517; GO:0010575; GO:0042803; GO:0008593\tP42227\t\tciliary neurotrophic factor receptor activity; ciliary neurotrophic factor receptor complex; dendrite; external side of plasma membrane; extracellular region; extracellular space; glycogen metabolic process; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-11 receptor activity; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-27 receptor activity; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 receptor complex; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6-mediated signaling pathway; leukemia inhibitory factor signaling pathway; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6-mediated signaling pathway; neuronal cell body; oncostatin-M receptor complex; oncostatin-M-mediated signaling pathway; positive regulation of T cell proliferation; positive regulation of acute inflammatory response; positive regulation of adaptive immune response; positive regulation of astrocyte differentiation; positive regulation of cardiac muscle hypertrophy; positive regulation of osteoblast differentiation; positive regulation of tyrosine phosphorylation of Stat1 protein; positive regulation of tyrosine phosphorylation of Stat3 protein; positive regulation vascular endothelial growth factor production; protein homodimerization activity; regulation of Notch signaling pathway\treviewed\tIPR003961; IPR003529; IPR013783; IPR010457; IPR015321;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)\tIL6ST\tHomo sapiens (Human)\t918\r",
        "\r\n",
        "Phel_clc_contig_230\tsp\tQ3UHC7\tDAB2P_MOUSE\t47.85\t604\t289\t11\t4531\t2780\t65\t662\t8E-171\t558\tQ3UHC7\tDAB2P_MOUSE\tGO:0007252; GO:0005099; GO:0017124; GO:0000185; GO:0001525; GO:0007049; GO:0021814; GO:0044257; GO:0071347; GO:0071222; GO:0071356; GO:0035924; GO:0044300; GO:0044301; GO:0030425; GO:0030139; GO:0006954; GO:0045087; GO:0070059; GO:0031235; GO:0021819; GO:0070373; GO:0070317; GO:0043124; GO:0043407; GO:0032088; GO:0034261; GO:0046580; GO:0016525; GO:0035414; GO:2000599; GO:0010596; GO:0050680; GO:0010719; GO:0048147; GO:0043553; GO:0014067; GO:0034144; GO:0000122; GO:0030948; GO:1900747; GO:0048812; GO:0032809; GO:1990032; GO:0036312; GO:0032266; GO:0070273; GO:0046330; GO:0043507; GO:0043065; GO:2001235; GO:0071158; GO:1900006; GO:0050679; GO:2001224; GO:1901800; GO:0090129; GO:0045944; GO:0032403; GO:0032312; GO:0040008; GO:1900744; GO:0043254; GO:0006986; GO:0035148; GO:0036324\tP97318\t\tI-kappaB phosphorylation; Ras GTPase activator activity; SH3 domain binding; activation of MAPKKK activity; angiogenesis; cell cycle; cell motility involved in cerebral cortex radial glia guided migration; cellular protein catabolic process; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; cellular response to lipopolysaccharide; cellular response to tumor necrosis factor; cellular response to vascular endothelial growth factor stimulus; cerebellar mossy fiber; climbing fiber; dendrite; endocytic vesicle; inflammatory response; innate immune response; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; intrinsic to internal side of plasma membrane; layer formation in cerebral cortex; negative regulation of ERK1 and ERK2 cascade; negative regulation of G0 to G1 transition; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of MAP kinase activity; negative regulation of NF-kappaB transcription factor activity; negative regulation of Ras GTPase activity; negative regulation of Ras protein signal transduction; negative regulation of angiogenesis; negative regulation of catenin import into nucleus; negative regulation of cyclin catabolic process; negative regulation of endothelial cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; negative regulation of fibroblast proliferation; negative regulation of phosphatidylinositol 3-kinase activity; negative regulation of phosphatidylinositol 3-kinase cascade; negative regulation of toll-like receptor 4 signaling pathway; negative regulation of transcription from RNA polymerase II promoter; negative regulation of vascular endothelial growth factor receptor signaling pathway; negative regulation of vascular endothelial growth factor signaling pathway; neuron projection morphogenesis; neuronal cell body membrane; parallel fiber; phosphatidylinositol 3-kinase regulatory subunit binding; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; positive regulation of JNK cascade; positive regulation of JUN kinase activity; positive regulation of apoptotic process; positive regulation of apoptotic signaling pathway; positive regulation of cell cycle arrest; positive regulation of dendrite development; positive regulation of epithelial cell proliferation; positive regulation of neuron migration; positive regulation of proteasomal protein catabolic process; positive regulation of synapse maturation; positive regulation of transcription from RNA polymerase II promoter; protein complex binding; regulation of ARF GTPase activity; regulation of growth; regulation of p38MAPK cascade; regulation of protein complex assembly; response to unfolded protein; tube formation; vascular endothelial growth factor receptor-2 signaling pathway\treviewed\tIPR000008; IPR021887; IPR011993; IPR001849; IPR001936; IPR023152; IPR008936;\t\tDisabled homolog 2-interacting protein (DAB2-interacting protein) (ASK-interacting protein 1) (DOC-2/DAB-2 interactive protein)\tDab2ip Kiaa1743\tMus musculus (Mouse)\t1189\r",
        "\r\n",
        "Phel_clc_contig_23729\tsp\tP18265\tGSK3A_RAT\t79.18\t317\t57\t2\t1\t945\t154\t463\t0\t516\tP18265\tGSK3A_RAT\tGO:0005524; GO:0016055; GO:0003214; GO:0016477; GO:0036016; GO:0071285; GO:0071407; GO:0005829; GO:0097192; GO:0005977; GO:0044027; GO:0008286; GO:0032007; GO:0061052; GO:0007399; GO:0071879; GO:0030819; GO:2000467; GO:0045823; GO:1901030; GO:0033138; GO:0010800; GO:0045944; GO:0043161; GO:0004674; GO:0006349; GO:0003073; GO:0050321\t\t\tATP binding; Wnt receptor signaling pathway; cardiac left ventricle morphogenesis; cell migration; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-3; cellular response to lithium ion; cellular response to organic cyclic compound; cytosol; extrinsic apoptotic signaling pathway in absence of ligand; glycogen metabolic process; hypermethylation of CpG island; insulin receptor signaling pathway; negative regulation of TOR signaling cascade; negative regulation of cell growth involved in cardiac muscle cell development; nervous system development; positive regulation of adrenergic receptor signaling pathway; positive regulation of cAMP biosynthetic process; positive regulation of glycogen (starch) synthase activity; positive regulation of heart contraction; positive regulation of mitochondrial outer membrane permeabilization; positive regulation of peptidyl-serine phosphorylation; positive regulation of peptidyl-threonine phosphorylation; positive regulation of transcription from RNA polymerase II promoter; proteasomal ubiquitin-dependent protein catabolic process; protein serine/threonine kinase activity; regulation of gene expression by genetic imprinting; regulation of systemic arterial blood pressure; tau-protein kinase activity\treviewed\tIPR011009; IPR000719; IPR017441; IPR002290; IPR008271;\t\tGlycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)\tGsk3a\tRattus norvegicus (Rat)\t483\r",
        "\r\n",
        "Phel_clc_contig_2386\tsp\tP27659\tRL3_MOUSE\t75.92\t299\t72\t0\t1\t897\t105\t403\t2E-151\t443\tP27659\tRL3_MOUSE\tGO:0071353; GO:0022625; GO:0005730; GO:0003735; GO:0006412\t\t\tcellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4; cytosolic large ribosomal subunit; nucleolus; structural constituent of ribosome; translation\treviewed\tIPR000597; IPR019926; IPR009000;\t\t60S ribosomal protein L3 (J1 protein)\tRpl3\tMus musculus (Mouse)\t403\r",
        "\r\n",
        "Phel_clc_contig_23906\tsp\tQ95115\tSTA5A_BOVIN\t49.55\t440\t212\t4\t208\t1524\t1\t431\t6E-132\t409\tQ95115\tSTA5A_BOVIN\tGO:0003677; GO:0007259; GO:0043029; GO:0005509; GO:0005737; GO:0046543; GO:0007565; GO:0007595; GO:0019915; GO:0001553; GO:0001779; GO:0043066; GO:0045647; GO:0005634; GO:0045579; GO:0042104; GO:0050729; GO:0045086; GO:0045931; GO:0040018; GO:0045944; GO:0038161; GO:0030155; GO:0030856; GO:0019218; GO:0003700; GO:0004871; GO:0006351\t\t\tDNA binding; JAK-STAT cascade; T cell homeostasis; calcium ion binding; cytoplasm; development of secondary female sexual characteristics; female pregnancy; lactation; lipid storage; luteinization; natural killer cell differentiation; negative regulation of apoptotic process; negative regulation of erythrocyte differentiation; nucleus; positive regulation of B cell differentiation; positive regulation of activated T cell proliferation; positive regulation of inflammatory response; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 biosynthetic process; positive regulation of mitotic cell cycle; positive regulation of multicellular organism growth; positive regulation of transcription from RNA polymerase II promoter; prolactin signaling pathway; regulation of cell adhesion; regulation of epithelial cell differentiation; regulation of steroid metabolic process; sequence-specific DNA binding transcription factor activity; signal transducer activity; transcription, DNA-dependent\treviewed\tIPR011992; IPR008967; IPR000980; IPR001217; IPR013800; IPR015988; IPR013801; IPR012345; IPR013799;\t\tSignal transducer and activator of transcription 5A (Mammary gland factor)\tSTAT5A MGF\tBos taurus (Bovine)\t794\r",
        "\r\n",
        "Phel_clc_contig_2392\tsp\tQ00612\tG6PD1_MOUSE\t70.04\t484\t145\t0\t136\t1587\t30\t513\t0\t754\tQ00612\tG6PD1_MOUSE\tGO:0050661; GO:0006741; GO:0001998; GO:0048821; GO:0051156; GO:0004345; GO:0006749; GO:0032613; GO:0032615; GO:0019322; GO:0006098; GO:0040014; GO:0006979; GO:0002033\t\t\tNADP binding; NADP biosynthetic process; angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure; erythrocyte development; glucose 6-phosphate metabolic process; glucose-6-phosphate dehydrogenase activity; glutathione metabolic process; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 production; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 production; pentose biosynthetic process; pentose-phosphate shunt; regulation of multicellular organism growth; response to oxidative stress; vasodilation by angiotensin involved in regulation of systemic arterial blood pressure\treviewed\tIPR001282; IPR019796; IPR022675; IPR022674; IPR016040;\tCarbohydrate degradation; pentose phosphate pathway; D-ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage): step 1/3.\tGlucose-6-phosphate 1-dehydrogenase X (G6PD) (EC 1.1.1.49)\tG6pdx G6pd G6pd-1\tMus musculus (Mouse)\t515\r",
        "\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_2450\tsp\tB6ZK77\tIRL1B_DANRE\t24.77\t214\t140\t6\t622\t20\t148\t353\t3E-09\t62\tB6ZK77\tIRL1B_DANRE\tGO:0043679; GO:0005737; GO:0016021; GO:0016322; GO:0043025; GO:0005886; GO:0007165; GO:0050808\t\t\taxon terminus; cytoplasm; integral to membrane; neuron remodeling; neuronal cell body; plasma membrane; signal transduction; synapse organization\treviewed\tIPR007110; IPR013783; IPR003599; IPR003598; IPR015621; IPR000157;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-1 receptor accessory protein-like 1-B\til1rapl1b\tDanio rerio (Zebrafish) (Brachydanio rerio)\t700\r",
        "\r\n",
        "Phel_clc_contig_25410\tsp\tQ3T0B6\tC1QBP_BOVIN\t33.33\t117\t70\t4\t149\t487\t164\t276\t2E-08\t55.5\tQ3T0B6\tC1QBP_BOVIN\tGO:0008380; GO:0031690; GO:0006915; GO:0009986; GO:0006958; GO:0001849; GO:0005737; GO:0005829; GO:0005576; GO:0005540; GO:0045087; GO:0030984; GO:0003729; GO:0006397; GO:0042256; GO:0005759; GO:0097177; GO:0039534; GO:0039536; GO:0050687; GO:0032689; GO:0032695; GO:0048025; GO:0000122; GO:0005730; GO:0005634; GO:0014065; GO:0005886; GO:0043065; GO:2000510; GO:0070131; GO:0090023; GO:0051897; GO:1900026; GO:1901165; GO:0030449; GO:0003714; GO:0006351\t\t\tRNA splicing; adrenergic receptor binding; apoptotic process; cell surface; complement activation, classical pathway; complement component C1q binding; cytoplasm; cytosol; extracellular region; hyaluronic acid binding; innate immune response; kininogen binding; mRNA binding; mRNA processing; mature ribosome assembly; mitochondrial matrix; mitochondrial ribosome binding; negative regulation of MDA-5 signaling pathway; negative regulation of RIG-I signaling pathway; negative regulation of defense response to virus; negative regulation of interferon-gamma production; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12 production; negative regulation of mRNA splicing, via spliceosome; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleus; phosphatidylinositol 3-kinase cascade; plasma membrane; positive regulation of apoptotic process; positive regulation of dendritic cell chemotaxis; positive regulation of mitochondrial translation; positive regulation of neutrophil chemotaxis; positive regulation of protein kinase B signaling cascade; positive regulation of substrate adhesion-dependent cell spreading; positive regulation of trophoblast cell migration; regulation of complement activation; transcription corepressor activity; transcription, DNA-dependent\treviewed\tIPR003428;\t\tComplement component 1 Q subcomponent-binding protein, mitochondrial\tC1QBP\tBos taurus (Bovine)\t278\r",
        "\r\n",
        "Phel_clc_contig_25861\tsp\tQ16594\tTAF9_HUMAN\t53.67\t177\t74\t4\t19\t528\t10\t185\t2E-61\t201\tQ16594\tTAF9_HUMAN\tGO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0043066; GO:1902166; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0006974; GO:0070555; GO:0003713; GO:0006368; GO:0005669; GO:0033276; GO:0006367; GO:0044212; GO:0016032\tQ92831; Q9Y6J9\t\tMLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to DNA damage stimulus; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; transcription factor TFTC complex; transcription initiation from RNA polymerase II promoter; transcription regulatory region DNA binding; viral process\treviewed\tIPR009072; IPR003162;\t\tTranscription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32)\tTAF9 TAF2G TAFII31\tHomo sapiens (Human)\t264\r",
        "\r\n",
        "Phel_clc_contig_25937\tsp\tQ60614\tAA2BR_MOUSE\t30.2\t298\t183\t7\t979\t146\t11\t303\t1E-27\t115\tQ60614\tAA2BR_MOUSE\tGO:0001609; GO:0004930; GO:0007189; GO:0031668; GO:0016021; GO:0005886; GO:0030819; GO:0030828; GO:0032722; GO:0002882; GO:0031284; GO:0032755; GO:0043306; GO:0010575; GO:0060087\t\t\tG-protein coupled adenosine receptor activity; G-protein coupled receptor activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; cellular response to extracellular stimulus; integral to membrane; plasma membrane; positive regulation of cAMP biosynthetic process; positive regulation of cGMP biosynthetic process; positive regulation of chemokine production; positive regulation of chronic inflammatory response to non-antigenic stimulus; positive regulation of guanylate cyclase activity; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of mast cell degranulation; positive regulation vascular endothelial growth factor production; relaxation of vascular smooth muscle\treviewed\tIPR001435; IPR001634; IPR000276; IPR017452;\t\tAdenosine receptor A2b\tAdora2b\tMus musculus (Mouse)\t332\r",
        "\r\n",
        "Phel_clc_contig_26237\tsp\tO08836\tIGBP1_RAT\t39.29\t224\t119\t5\t686\t39\t67\t281\t9E-38\t139\tO08836\tIGBP1_RAT\tGO:0042113; GO:0005737; GO:0043066; GO:0043154; GO:0035308; GO:0032873; GO:0000122; GO:0035306; GO:0045944; GO:0008601; GO:0060632; GO:0070555; GO:0034612\t\t\tB cell activation; cytoplasm; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of protein dephosphorylation; negative regulation of stress-activated MAPK cascade; negative regulation of transcription from RNA polymerase II promoter; positive regulation of dephosphorylation; positive regulation of transcription from RNA polymerase II promoter; protein phosphatase type 2A regulator activity; regulation of microtubule-based movement; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; response to tumor necrosis factor\treviewed\tIPR007304;\t\tImmunoglobulin-binding protein 1 (Alpha4 phosphoprotein) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit)\tIgbp1\tRattus norvegicus (Rat)\t340\r",
        "\r\n",
        "Phel_clc_contig_2624\tsp\tQ8CIS0\tCAR11_MOUSE\t26.64\t428\t258\t13\t2881\t1673\t11\t407\t3E-12\t74.7\tQ8CIS0\tCAR11_MOUSE\tGO:0031295; GO:0042101; GO:0005737; GO:0045121; GO:0005886; GO:0030890; GO:0043123; GO:0051092; GO:0042102; GO:0001819; GO:0045086; GO:0045577; GO:0045580; GO:0042981; GO:0050776; GO:0007165; GO:0045061\t\t\tT cell costimulation; T cell receptor complex; cytoplasm; membrane raft; plasma membrane; positive regulation of B cell proliferation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of NF-kappaB transcription factor activity; positive regulation of T cell proliferation; positive regulation of cytokine production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 biosynthetic process; regulation of B cell differentiation; regulation of T cell differentiation; regulation of apoptotic process; regulation of immune response; signal transduction; thymic T cell selection\treviewed\tIPR001315; IPR011029; IPR027417; IPR001478;\t\tCaspase recruitment domain-containing protein 11\tCard11\tMus musculus (Mouse)\t1159\r",
        "\r\n",
        "Phel_clc_contig_26324\tsp\tQ96P20\tNALP3_HUMAN\t25\t216\t143\t7\t2410\t1793\t328\t534\t3E-08\t61.6\tQ96P20\tNALP3_HUMAN\tGO:0005524; GO:0072559; GO:0006919; GO:0071222; GO:0005829; GO:0051607; GO:0009595; GO:0006954; GO:0045087; GO:0050701; GO:0032621; GO:0042347; GO:0032088; GO:0002674; GO:0050713; GO:0035872; GO:0042834; GO:0051092; GO:0043280; GO:0050718; GO:0051259\tQ7Z434; Q9ULZ3\t\tATP binding; NLRP3 inflammasome complex; activation of cysteine-type endopeptidase activity involved in apoptotic process; cellular response to lipopolysaccharide; cytosol; defense response to virus; detection of biotic stimulus; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 secretion; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-18 production; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of acute inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; peptidoglycan binding; positive regulation of NF-kappaB transcription factor activity; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; protein oligomerization\treviewed\tIPR004020; IPR011029; IPR003590; IPR007111; IPR027417;\t\tNACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)\tNLRP3 C1orf7 CIAS1 NALP3 PYPAF1\tHomo sapiens (Human)\t1036\r",
        "\r\n",
        "Phel_clc_contig_273\tsp\tP17676\tCEBPB_HUMAN\t52.05\t73\t35\t0\t2229\t2011\t262\t334\t3E-15\t82\tP17676\tCEBPB_HUMAN\tGO:0003677; GO:0001077; GO:0003705; GO:0006953; GO:0050873; GO:0071230; GO:0005737; GO:0001892; GO:0006955; GO:0060644; GO:0033598; GO:0043066; GO:0045892; GO:0030182; GO:0000790; GO:0016363; GO:0005634; GO:0045669; GO:0045408; GO:0034976; GO:0032496; GO:0043565\tQ86X55; P03120; P03122; P06422; P06790; P04637\t\tDNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; acute-phase response; brown fat cell differentiation; cellular response to amino acid stimulus; cytoplasm; embryonic placenta development; immune response; mammary gland epithelial cell differentiation; mammary gland epithelial cell proliferation; negative regulation of apoptotic process; negative regulation of transcription, DNA-dependent; ne"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "uron differentiation; nuclear chromatin; nuclear matrix; nucleus; positive regulation of osteoblast differentiation; regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 biosynthetic process; response to endoplasmic reticulum stress; response to lipopolysaccharide; sequence-specific DNA binding\treviewed\tIPR004827; IPR016468;\t\tCCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5)\tCEBPB TCF5 PP9092\tHomo sapiens (Human)\t345\r",
        "\r\n",
        "Phel_clc_contig_27934\tsp\tP41233\tABCA1_MOUSE\t41.38\t203\t108\t5\t594\t1\t730\t926\t8E-39\t148\tP41233\tABCA1_MOUSE\tGO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691\t\t\tATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport\treviewed\tIPR003593; IPR026082; IPR003439; IPR017871; IPR027417;\t\tATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)\tAbca1 Abc1\tMus musculus (Mouse)\t2261\r",
        "\r\n",
        "Phel_clc_contig_28082\tsp\tQ645M6\tFADD_BOVIN\t31.34\t67\t45\t1\t245\t45\t101\t166\t3E-06\t49.7\tQ645M6\tFADD_BOVIN\tGO:0031265; GO:0097202; GO:0071260; GO:0051607; GO:0097191; GO:0045087; GO:0070265; GO:0043123; GO:0043065; GO:2001238; GO:0032757; GO:0045862; GO:0045944; GO:0032760; GO:0060340\t\t\tCD95 death-inducing signaling complex; activation of cysteine-type endopeptidase activity; cellular response to mechanical stimulus; defense response to virus; extrinsic apoptotic signaling pathway; innate immune response; necrotic cell death; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of extrinsic apoptotic signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of tumor necrosis factor production; positive regulation of type I interferon-mediated signaling pathway\treviewed\tIPR011029; IPR000488; IPR001875; IPR016729;\t\tProtein FADD (FAS-associated death domain protein) (FAS-associating death domain-containing protein)\tFADD\tBos taurus (Bovine)\t209\r",
        "\r\n",
        "Phel_clc_contig_28217\tsp\tP16581\tLYAM2_HUMAN\t27.08\t277\t153\t15\t967\t152\t270\t502\t6E-09\t62\tP16581\tLYAM2_HUMAN\tGO:0030029; GO:0007202; GO:0007596; GO:0019722; GO:0005901; GO:0005905; GO:0030863; GO:0005615; GO:0007157; GO:0016021; GO:0002523; GO:0050901; GO:0070492; GO:0048471; GO:0043274; GO:0002687; GO:0002092; GO:0050727; GO:0070555; GO:0032496; GO:0034612; GO:0033691; GO:0004888\t\t\tactin filament-based process; activation of phospholipase C activity; blood coagulation; calcium-mediated signaling; caveola; coated pit; cortical cytoskeleton; extracellular space; heterophilic cell-cell adhesion; integral to membrane; leukocyte migration involved in inflammatory response; leukocyte tethering or rolling; oligosaccharide binding; perinuclear region of cytoplasm; phospholipase binding; positive regulation of leukocyte migration; positive regulation of receptor internalization; regulation of inflammatory response; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; response to lipopolysaccharide; response to tumor necrosis factor; sialic acid binding; transmembrane signaling receptor activity\treviewed\tIPR001304; IPR016186; IPR018378; IPR016187; IPR000742; IPR013032; IPR002396; IPR000436;\t\tE-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E)\tSELE ELAM1\tHomo sapiens (Human)\t610\r",
        "\r\n",
        "Phel_clc_contig_2843\tsp\tQ9H0E2\tTOLIP_HUMAN\t47.85\t303\t119\t6\t1468\t581\t1\t271\t5E-78\t251\tQ9H0E2\tTOLIP_HUMAN\tGO:0007267; GO:0005829; GO:0006954; GO:0045087; GO:0045323; GO:0045092; GO:0035556; GO:0045321; GO:0016604; GO:0048471; GO:0016310; GO:0033235; GO:0004871\tQ05048; Q15038; Q86Y13; P19525; O43187; Q86TG7; O75674; Q96S55\t\tcell-cell signaling; cytosol; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor complex; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-18 receptor complex; intracellular signal transduction; leukocyte activation; nuclear body; perinuclear region of cytoplasm; phosphorylation; positive regulation of protein sumoylation; signal transducer activity\treviewed\tIPR000008; IPR003892; IPR009060;\t\tToll-interacting protein\tTOLLIP\tHomo sapiens (Human)\t274\r",
        "\r\n",
        "Phel_clc_contig_2906\tsp\tP70451\tFER_MOUSE\t41.72\t839\t458\t13\t6122\t3648\t1\t822\t0\t643\tP70451\tFER_MOUSE\tGO:0005524; GO:0038095; GO:0038109; GO:0015629; GO:0031532; GO:0005938; GO:0030054; GO:0008283; GO:0044331; GO:0036006; GO:0034614; GO:0006935; GO:0005737; GO:0050904; GO:0005154; GO:0035426; GO:0031234; GO:0038028; GO:0070102; GO:0030027; GO:0008289; GO:0015630; GO:0000226; GO:0000278; GO:0033007; GO:0004715; GO:0000790; GO:0048008; GO:0051092; GO:0030838; GO:0030335; GO:0046777; GO:0042058; GO:0010762; GO:0010591; GO:0001932; GO:0032496; GO:0036119; GO:0034446; GO:0042503\t\t\tATP binding; Fc-epsilon receptor signaling pathway; Kit signaling pathway; actin cytoskeleton; actin cytoskeleton reorganization; cell cortex; cell junction; cell proliferation; cell-cell adhesion mediated by cadherin; cellular response to macrophage colony-stimulating factor stimulus; cellular response to reactive oxygen species; chemotaxis; cytoplasm; diapedesis; epidermal growth factor receptor binding; extracellular matrix-cell signaling; extrinsic to internal side of plasma membrane; insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6-mediated signaling pathway; lamellipodium; lipid binding; microtubule cytoskeleton; microtubule cytoskeleton organization; mitotic cell cycle; negative regulation of mast cell activation involved in immune response; non-membrane spanning protein tyrosine kinase activity; nuclear chromatin; platelet-derived growth factor receptor signaling pathway; positive regulation of NF-kappaB transcription factor activity; positive regulation of actin filament polymerization; positive regulation of cell migration; protein autophosphorylation; regulation of epidermal growth factor receptor signaling pathway; regulation of fibroblast migration; regulation of lamellipodium assembly; regulation of protein phosphorylation; response to lipopolysaccharide; response to platelet-derived growth factor stimulus; substrate adhesion-dependent cell spreading; tyrosine phosphorylation of Stat3 protein\treviewed\tIPR001060; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR008266; IPR020635; IPR016250;\t\tTyrosine-protein kinase Fer (EC 2.7.10.2) (Proto-oncogene c-Fer) (p94-Fer)\tFer Fert2\tMus musculus (Mouse)\t823\r",
        "\r\n",
        "Phel_clc_contig_2959\tsp\tQ5GLH2\tTRIB2_BOVIN\t62.18\t156\t58\t1\t1\t468\t188\t342\t9E-57\t199\tQ5GLH2\tTRIB2_BOVIN\tGO:0005737; GO:0005856; GO:0045599; GO:0045081; GO:0006469; GO:0005634; GO:0032436; GO:0004860; GO:0043405; GO:0016772; GO:0055106\t\t\tcytoplasm; cytoskeleton; negative regulation of fat cell differentiation; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 biosynthetic process; negative regulation of protein kinase activity; nucleus; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; protein kinase inhibitor activity; regulation of MAP kinase activity; transferase activity, transferring phosphorus-containing groups; ubiquitin-protein ligase regulator activity\treviewed\tIPR011009; IPR000719; IPR024104;\t\tTribbles homolog 2 (TRB-2)\tTRIB2\tBos taurus (Bovine)\t343\r",
        "\r\n",
        "Phel_clc_contig_29696\tsp\tP01023\tA2MG_HUMAN\t39.37\t447\t246\t14\t3\t1298\t802\t1238\t2E-77\t267\tP01023\tA2MG_HUMAN\tGO:0007597; GO:0005829; GO:0005615; GO:0070062; GO:0019966; GO:0001869; GO:0030168; GO:0031093; GO:0002576; GO:0051056; GO:0004867; GO:0007264; GO:0048863; GO:0043120\t\t\tblood coagulation, intrinsic pathway; cytosol; extracellular space; extracellular vesicular exosome; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 binding; negative regulation of complement activation, lectin pathway; platelet activation; platelet alpha granule lumen; platelet degranulation; regulation of small GTPase mediated signal transduction; serine-type endopeptidase inhibitor activity; small GTPase mediated signal transduction; stem cell differentiation; tumor necrosis factor binding\treviewed\tIPR009048; IPR011626; IPR002890; IPR011625; IPR014756; IPR001599; IPR019742; IPR019565; IPR008930; IPR010916;\t\tAlpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)\tA2M CPAMD5 FWP007\tHomo sapiens (Human)\t1474\r",
        "\r\n",
        "Phel_clc_contig_30020\tsp\tO35516\tNOTC2_MOUSE\t52.17\t46\t22\t0\t434\t297\t1014\t1059\t1E-07\t54.3\tO35516\tNOTC2_MOUSE\tGO:0007219; GO:0060413; GO:0005509; GO:0007050; GO:0001709; GO:0016049; GO:0009986; GO:0061073; GO:0005829; GO:0030326; GO:0005576; GO:0072104; GO:0072015; GO:0001947; GO:0006959; GO:0001701; GO:0002437; GO:0005887; GO:0072602; GO:0070986; GO:0002011; GO:0008285; GO:0000122; GO:0005654; GO:0060674; GO:0030513; GO:0046579; GO:0043065; GO:0008284; GO:0045672; GO:0072014; GO:0006351; GO:0042060\t\t\tNotch signaling pathway; atrial septum morphogenesis; calcium ion binding; cell cycle arrest; cell fate determination; cell growth; cell surface; ciliary body morphogenesis; cytosol; embryonic limb morphogenesis; extracellular region; glomerular capillary formation; glomerular visceral epithelial cell development; heart looping; humoral immune response; in utero embryonic development; inflammatory response to antigenic stimulus; integral to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4 secretion; left/right axis specification; morphogenesis of an epithelial sheet; negative regulation of cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; placenta blood vessel development; positive regulation of BMP signaling pathway; positive regulation of Ras protein signal transduction; positive regulation of apoptotic process; positive regulation of cell proliferation; positive regulation of osteoclast differentiation; proximal tubule development; transcription, DNA-dependent; wound healing\treviewed\tIPR002110; IPR020683; IPR024600; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR008297; IPR022336; IPR000800; IPR010660; IPR011656;\t\tNeurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]\tNotch2\tMus musculus (Mouse)\t2470\r",
        "\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_3432\tsp\tQ62018\tCTR9_MOUSE\t77.45\t683\t154\t0\t324\t2372\t210\t892\t0\t1095\tQ62018\tCTR9_MOUSE\tGO:0016593; GO:0007259; GO:0042169; GO:0016055; GO:0071222; GO:0001711; GO:0033523; GO:0080182; GO:0010390; GO:0070102; GO:0045638; GO:0000122; GO:0016607; GO:0051571; GO:2001162; GO:0032968; GO:0045944; GO:0019827; GO:0006351; GO:0035327\t\t\tCdc73/Paf1 complex; JAK-STAT cascade; SH2 domain binding; Wnt receptor signaling pathway; cellular response to lipopolysaccharide; endodermal cell fate commitment; histone H2B ubiquitination; histone H3-K4 trimethylation; histone monoubiquitination; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6-mediated signaling pathway; negative regulation of myeloid cell differentiation; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; positive regulation of histone H3-K4 methylation; positive regulation of histone H3-K79 methylation; positive regulation of transcription elongation from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; stem cell maintenance; transcription, DNA-dependent; transcriptionally active chromatin\treviewed\tIPR013026; IPR011990; IPR001440; IPR013105; IPR019734;\t\tRNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1) (Tetratricopeptide repeat-containing, SH2-binding phosphoprotein of 150 kDa) (TPR-containing, SH2-binding phosphoprotein of 150 kDa) (p150TSP)\tCtr9 Kiaa0155 Sh2bp1\tMus musculus (Mouse)\t1173\r",
        "\r\n",
        "Phel_clc_contig_3793\tsp\tQ5GLH2\tTRIB2_BOVIN\t51.79\t195\t90\t3\t1158\t1733\t1\t194\t2E-50\t182\tQ5GLH2\tTRIB2_BOVIN\tGO:0005737; GO:0005856; GO:0045599; GO:0045081; GO:0006469; GO:0005634; GO:0032436; GO:0004860; GO:0043405; GO:0016772; GO:0055106\t\t\tcytoplasm; cytoskeleton; negative regulation of fat cell differentiation; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 biosynthetic process; negative regulation of protein kinase activity; nucleus; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; protein kinase inhibitor activity; regulation of MAP kinase activity; transferase activity, transferring phosphorus-containing groups; ubiquitin-protein ligase regulator activity\treviewed\tIPR011009; IPR000719; IPR024104;\t\tTribbles homolog 2 (TRB-2)\tTRIB2\tBos taurus (Bovine)\t343\r",
        "\r\n",
        "Phel_clc_contig_3838\tsp\tQ9EPI1\tXYLT1_RAT\t48.69\t723\t355\t7\t2862\t709\t110\t821\t0\t751\tQ9EPI1\tXYLT1_RAT\tGO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0015012; GO:0048681; GO:0030158; GO:0030166; GO:0070555\t\t\tGolgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; heparan sulfate proteoglycan biosynthetic process; negative regulation of axon regeneration; protein xylosyltransferase activity; proteoglycan biosynthetic process; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1\treviewed\tIPR003406; IPR024448;\tGlycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis.\tXylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (Fragment)\tXylt1\tRattus norvegicus (Rat)\t821\r",
        "\r\n",
        "Phel_clc_contig_3848\tsp\tP41233\tABCA1_MOUSE\t47.99\t971\t456\t17\t7317\t4486\t1299\t2247\t0\t860\tP41233\tABCA1_MOUSE\tGO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691\t\t\tATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport\treviewed\tIPR003593; IPR026082; IPR003439; IPR017871; IPR027417;\t\tATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)\tAbca1 Abc1\tMus musculus (Mouse)\t2261\r",
        "\r\n",
        "Phel_clc_contig_3999\tsp\tQ25C79\tAKIR2_RAT\t43.61\t227\t83\t7\t282\t911\t1\t199\t8E-27\t115\tQ25C79\tAKIR2_RAT\tGO:0009790; GO:0045087; GO:0000122; GO:0008284; GO:0010950; GO:0032755; GO:0045944; GO:0032496; GO:0006351; GO:0017053\t\t\tembryo development; innate immune response; negative regulation of transcription from RNA polymerase II promoter; positive regulation of cell proliferation; positive regulation of endopeptidase activity; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of transcription from RNA polymerase II promoter; response to lipopolysaccharide; transcription, DNA-dependent; transcriptional repressor complex\treviewed\tIPR024132;\t\tAkirin-2 (Fourteen-three-three beta interactant 1) (Fourteen-three-three beta interacting-protein 1)\tAkirin2 FBI1\tRattus norvegicus (Rat)\t201\r",
        "\r\n",
        "Phel_clc_contig_4093\tsp\tQ9Z2F6\tBCL3_MOUSE\t30.86\t256\t153\t6\t960\t193\t125\t356\t6E-24\t110\tQ9Z2F6\tBCL3_MOUSE\tGO:0032996; GO:0033257; GO:0003677; GO:0030330; GO:0007249; GO:0042088; GO:0045064; GO:0019730; GO:0042742; GO:0042832; GO:0030198; GO:0002268; GO:0002467; GO:0002455; GO:0042771; GO:0002315; GO:0043066; GO:0045415; GO:0045892; GO:0042536; GO:0005634; GO:0048471; GO:0032729; GO:0045082; GO:0045944; GO:0045727; GO:0000060; GO:0051101; GO:0042345; GO:0010225; GO:0009615; GO:0003700; GO:0048536; GO:0006351\tQ80TQ2\t\tBcl3-Bcl10 complex; Bcl3/NF-kappaB2 complex; DNA binding; DNA damage response, signal transduction by p53 class mediator; I-kappaB kinase/NF-kappaB cascade; T-helper 1 type immune response; T-helper 2 cell differentiation; antimicrobial humoral response; defense response to bacterium; defense response to protozoan; extracellular matrix organization; follicular dendritic cell differentiation; germinal center formation; humoral immune response mediated by circulating immunoglobulin; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; marginal zone B cell differentiation; negative regulation of apoptotic process; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 biosynthetic process; negative regulation of transcription, DNA-dependent; negative regulation of tumor necrosis factor biosynthetic process; nucleus; perinuclear region of cytoplasm; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translation; protein import into nucleus, translocation; regulation of DNA binding; regulation of NF-kappaB import into nucleus; response to UV-C; response to virus; sequence-specific DNA binding transcription factor activity; spleen development; transcription, DNA-dependent\treviewed\tIPR002110; IPR020683;\t\tB-cell lymphoma 3 protein homolog (BCL-3)\tBcl3\tMus musculus (Mouse)\t448\r",
        "\r\n",
        "Phel_clc_contig_4609\tsp\tQ64287\tIRF4_MOUSE\t52.1\t119\t57\t0\t583\t939\t23\t141\t2E-33\t140\tQ64287\tIRF4_MOUSE\tGO:0072540; GO:0005737; GO:0042832; GO:0043966; GO:0043967; GO:0043011; GO:0034122; GO:0000788; GO:0043388; GO:0045082; GO:0045368; GO:0045086; GO:0045404; GO:0045944; GO:0016279; GO:0000975; GO:0043565; GO:0003700; GO:0006351\tO35284\t\tT-helper 17 cell lineage commitment; cytoplasm; defense response to protozoan; histone H3 acetylation; histone H4 acetylation; myeloid dendritic cell differentiation; negative regulation of toll-like receptor signaling pathway; nuclear nucleosome; positive regulation of DNA binding; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-10 biosynthetic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-13 biosynthetic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 biosynthetic process; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4 biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein-lysine N-methyltransferase activity; regulatory region DNA binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent\treviewed\tIPR019817; IPR001346; IPR019471; IPR017855; IPR008984; IPR011991;\t\tInterferon regulatory factor 4 (IRF-4) (Lymphocyte-specific interferon regulatory factor) (LSIRF) (NF-EM5) (PU.1 interaction partner) (Transcriptional activator PIP)\tIrf4 Spip\tMus musculus (Mouse)\t450\r",
        "\r\n",
        "Phel_clc_contig_4739\tsp\tO35615\tFOG1_MOUSE\t24.19\t248\t137\t8\t5420\t4752\t162\t383\t4E-08\t62.8\tO35615\tFOG1_MOUSE\tGO:0003677; GO:0001102; GO:0001078; GO:0060413; GO:0003181; GO:0055008; GO:0005737; GO:0060318; GO:0030851; GO:0035855; GO:0046872; GO:0003192; GO:0045599; GO:0045403; GO:0060377; GO:0032091; GO:0000122; GO:0005634; GO:0003151; GO:0030220; GO:0045078; GO:0060319; GO:0032642; GO:0010724; GO:0003714; GO:0005667; GO:0071733; GO:0017053; GO:0003195; GO:0060412\tQ9JJ11\t\tDNA binding; RNA polymerase II activating transcription factor binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; atrial septum morphogenesis; atrioventricular valve morphogenesis; cardiac muscle tissue morphogenesis; cytoplasm; definitive erythrocyte differentiation; granulocyte differentiation; megakaryocyte development; metal ion binding; mitral valve formation; negative regulation of fat cell differentiation; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4 biosynthetic process; negative regulation of mast cell differentiation; negative regulation of protein binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; outflow tract morphogenesis; platelet formation; positive regulation of interferon-gamma biosynthetic process; primitive erythrocyte differentiation; regulation of chemokine production; regulation of definitive erythrocyte differentiation; transcription corepressor activity; transcription factor complex; transcriptional activation by promoter-enhancer looping; transcriptional repressor complex; tricuspid valve formation; ventricular septum morphogenesis\treviewed\tIPR007087; IPR015880; IPR013087;\t\tZinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein multitype 1)\tZfpm1 Fog Fog1\tMus musculus (Mouse)\t995\r",
        "\r\n",
        "Phel_clc_contig_4793\tsp\tP41743\tKPCI_HUMAN\t70.78\t592\t149\t7\t4212\t2449\t25\t596\t0\t866\tP41743\tKPCI_HUMAN\tGO:0005524; GO:0048194; GO:0043220; GO:0007015; GO:0016324; GO:0031252; GO:0016477; GO:0032869; GO:0007010; GO:0005829; GO:0005768; GO:0035089; GO:0045197; GO:0042462; GO:0035556; GO:0034351; GO:0043524; GO:0048011; GO:0005634; GO:0005543; GO:0005886; GO:0000133; GO:0051092; GO:2000353; GO:0090004; GO:0060252; GO:0046326; GO:0010976; GO:0004697; GO:0006612; GO:0070555; GO:0046903; GO:0070830; GO:0016192; GO:0008270\tP60953; Q96L34; Q8TEW0; Q9NPB6; Q9BYG5; Q9BYG4; Q8ND90; P63000; Q13501; Q04917\t\tATP binding; Golgi vesicle budding; Schmidt-Lanterman incisure; actin filament organization; apical plasma membrane; cell leading edge; cell migration; cellular response to insulin stimulus; cytoskeleton organization; cytosol; endosome; establishment of apical/basal cell polarity; establishment or maintenance of epithelial cell apical/basal polarity; eye photoreceptor cell development; intracellular signal transduction; negative regulation of glial cell apoptotic process; negative regulation of neuron apoptotic process; neurotrophin TRK receptor signaling pathway; nucleus; phospholipid binding; plasma membrane; polarisome; positive regulation of NF-kappaB transcription factor activity; positive regulation of endothelial cell apoptotic process; positive regulation of establishment of protein localization to plasma membrane; positive regulation of glial cell proliferation; positive regulation of glucose import; positive regulation of neuron projection development; protein kinase C activity; protein targeting to membrane; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; secretion; tight junction assembly; vesicle-mediated transport; zinc ion binding\treviewed\tIPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271;\t\tProtein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota)\tPRKCI DXS1179E\tHomo sapiens (Human)\t596\r",
        "\r\n",
        "Phel_clc_contig_4867\tsp\tQ5U2S1\tNFIP1_RAT\t31.5\t200\t122\t3\t3332\t2748\t23\t212\t1E-21\t100\tQ5U2S1\tNFIP1_RAT\tGO:0000139; GO:0005938; GO:0006879; GO:0010008; GO:0005576; GO:0016021; GO:0042130; GO:0010629; GO:0050728; GO:0032713; GO:0048294; GO:0051224; GO:0032410; GO:0002829; GO:0048471; GO:0043123; GO:0045732; GO:0031398; GO:0048302; GO:0045619; GO:0002761; GO:0004871; GO:0043162\t\t\tGolgi membrane; cell cortex; cellular iron ion homeostasis; endosome membrane; extracellular region; integral to membrane; negative regulation of T cell proliferation; negative regulation of gene expression; negative regulation of inflammatory response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4 production; negative regulation of isotype switching to IgE isotypes; negative regulation of protein transport; negative regulation of transporter activity; negative regulation of type 2 immune response; perinuclear region of cytoplasm; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of protein catabolic process; positive regulation of protein ubiquitination; regulation of isotype switching to IgG isotypes; regulation of lymphocyte differentiation; regulation of myeloid leukocyte differentiation; signal transducer activity; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway\treviewed\tIPR019325;\t\tNEDD4 family-interacting protein 1\tNdfip1 N4wbp5\tRattus norvegicus (Rat)\t221\r",
        "\r\n",
        "Phel_clc_contig_5341\tsp\tP21580\tTNAP3_HUMAN\t29.82\t560\t290\t17\t3554\t2142\t60\t605\t2E-56\t214\tP21580\tTNAP3_HUMAN\tGO:0001922; GO:0003677; GO:0006915; GO:0070301; GO:0005813; GO:0005829; GO:0006954; GO:0045087; GO:0005764; GO:0050869; GO:2000349; GO:0043124; GO:0032088; GO:0045779; GO:0002677; GO:0045736; GO:2000352; GO:1902042; GO:0050728; GO:0045824; GO:0032691; GO:0032703; GO:0032715; GO:0070429; GO:0070433; GO:0090291; GO:0031397; GO:0048662; GO:0034136; GO:0034140; GO:0034148; GO:0032720; GO:0032480; GO:0070423; GO:0005634; GO:2000347; GO:0045732; GO:0035871; GO:0071108; GO:0070936; GO:0070536; GO:0051259; GO:0043621; GO:0006508; GO:0050691; GO:0002634; GO:0061043; GO:0032495; GO:0072573; GO:0004221; GO:0004842; GO:0004843; GO:0008270\tQ9Y6K9; Q9Y3C5; P68510\t\tB-1 B cell homeostasis; DNA binding; apoptotic process; cellular response to hydrogen peroxide; centrosome; cytosol; inflammatory response; innate immune response; lysosome; negative regulation of B cell activation; negative regulation of CD40 signaling pathway; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of bone resorption; negative regulation of chronic inflammatory response; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of endothelial cell apoptotic process; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; negative regulation of inflammatory response; negative regulation of innate immune response; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 beta production; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 production; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; negative regulation of osteoclast proliferation; negative regulation of protein ubiquitination; negative regulation of smooth muscle cell proliferation; negative regulation of toll-like receptor 2 signaling pathway; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of toll-like receptor 5 signaling pathway; negative regulation of tumor necrosis factor production; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; nucleus; positive regulation of hepatocyte proliferation; positive regulation of protein catabolic process; protein K11-linked deubiquitination; protein K48-linked deubiquitination; protein K48-linked ubiquitination; protein K63-linked deubiquitination; protein oligomerization; protein self-association; proteolysis; regulation of defense response to virus by host; regulation of germinal center formation; regulation of vascular wound healing; response to muramyl dipeptide; tolerance induction to lipopolysaccharide; ubiquitin thiolesterase activity; ubiquitin-protein ligase activity; ubiquitin-specific protease activity; zinc ion binding\treviewed\tIPR003323; IPR002653;\t\tTumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 3.4.19.12) (EC 6.3.2.-) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37]\tTNFAIP3 OTUD7C\tHomo sapiens (Human)\t790\r",
        "\r\n",
        "Phel_clc_contig_5598\tsp\tQ9CPT4\tCS010_MOUSE\t38.93\t131\t65\t5\t817\t458\t33\t159\t7E-21\t91.7\tQ9CPT4\tCS010_MOUSE\tGO:0005576\t\t\textracellular region\treviewed\tIPR018887;\t\tUPF0556 protein C19orf10 homolog (\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-25) (IL-25) (Stromal cell-derived growth factor SF20)\tD17Wsu104e Il25\tMus musculus (Mouse)\t166\r",
        "\r\n",
        "Phel_clc_contig_5636\tsp\tQ9WVF8\tTUSC2_MOUSE\t47.54\t61\t32\t0\t3798\t3616\t30\t90\t1E-08\t59.3\tQ9WVF8\tTUSC2_MOUSE\tGO:0048469; GO:0071609; GO:0006954; GO:0032618; GO:0005739; GO:0001779; GO:0051881; GO:2000377\t\t\tcell maturation; chemokine (C-C motif) ligand 5 production; inflammatory response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-15 production; mitochondrion; natural killer cell differentiation; regulation of mitochondrial membrane potential; regulation of reactive oxygen species metabolic process\treviewed\t\t\tTumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2)\tTusc2 Fus1 Lgcc Pdap2\tMus musculus (Mouse)\t110\r",
        "\r\n",
        "Phel_clc_contig_5757\tsp\tQ8K0F1\tTBC23_MOUSE\t55.28\t436\t185\t4\t2167\t884\t1\t434\t2E-147\t453\tQ8K0F1\tTBC23_MOUSE\tGO:0005097; GO:0032851; GO:0032755; GO:0050727; GO:0032680\t\t\tRab GTPase activator activity; positive regulation of Rab GTPase activity; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; regulation of inflammatory response; regulation of tumor necrosis factor production\treviewed\tIPR000195; IPR001763;\t\tTBC1 domain family member 23\tTbc1d23\tMus musculus (Mouse)\t684\r",
        "\r\n",
        "Phel_clc_contig_5928\tsp\tQ67E05\tBPI_MOUSE\t29.86\t221\t146\t5\t244\t903\t14\t226\t2E-16\t82.8\tQ67E05\tBPI_MOUSE\tGO:0005737; GO:0042742; GO:0005576; GO:0006955; GO:0001530; GO:0016020; GO:0032715; GO:0032717; GO:0043031; GO:0032720\t\t\tcytoplasm; defense response to bacterium; extracellular region; immune response; lipopolysaccharide binding; membrane; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; negative regulation of macrophage activation; negative regulation of tumor necrosis factor production\treviewed\tIPR017943; IPR001124; IPR017942;\t\tBactericidal permeability-increasing protein (BPI)\tBpi\tMus musculus (Mouse)\t483\r",
        "\r\n",
        "Phel_clc_contig_5929\tsp\tP17213\tBPI_HUMAN\t30\t260\t178\t3\t14\t790\t230\t486\t3E-31\t125\tP17213\tBPI_HUMAN\tGO:0005737; GO:0042742; GO:0005576; GO:0006955; GO:0005887; GO:0001530; GO:0032715; GO:0032717; GO:0043031; GO:0032720\t\t\tcytoplasm; defense response to bacterium; extracellular region; immune response; integral to plasma membrane; lipopolysaccharide binding; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; negative regulation of macrophage activation; negative regulation of tumor necrosis factor production\treviewed\tIPR017943; IPR001124; IPR017954; IPR017942;\t\tBactericidal permeability-increasing protein (BPI) (CAP 57)\tBPI\tHomo sapiens (Human)\t487\r",
        "\r\n",
        "Phel_clc_contig_5942\tsp\tP13716\tHEM2_HUMAN\t71.71\t251\t71\t0\t2\t754\t78\t328\t7E-119\t384\tP13716\tHEM2_HUMAN\tGO:0071353; GO:0005829; GO:0006783; GO:0032791; GO:0004655; GO:0051260; GO:0006782; GO:0044281; GO:0008270\t\t\tcellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4; cytosol; heme biosynthetic process; lead ion binding; porphobilinogen synthase activity; protein homooligomerization; protoporphyrinogen IX biosynthetic process; small molecule metabolic process; zinc ion binding\treviewed\tIPR013785; IPR001731;\tPorphyrin-containing compound metabolism; protoporphyrin-IX biosynthesis; coproporphyrinogen-III from 5-aminolevulinate: step 1/4.\tDelta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)\tALAD\tHomo sapiens (Human)\t330\r",
        "\r\n",
        "Phel_clc_contig_5989\tsp\tQ6IMZ0\tNFIL3_RAT\t47.37\t95\t47\t1\t2463\t2179\t32\t123\t9E-16\t85.1\tQ6IMZ0\tNFIL3_RAT\tGO:0001078; GO:0000979; GO:0071353; GO:0007623; GO:0005634; GO:0010628; GO:0003700\t\t\tRNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4; circadian rhythm; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity\treviewed\tIPR004827; IPR016743; IPR010533;\t\tNuclear factor \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-3-regulated protein (E4 promoter-binding protein 4)\tNfil3\tRattus norvegicus (Rat)\t462\r",
        "\r\n",
        "Phel_clc_contig_6203\tsp\tQ61160\tFADD_MOUSE\t31.28\t211\t97\t5\t2334\t1705\t18\t181\t2E-16\t84\tQ61160\tFADD_MOUSE\tGO:0031265; GO:0033077; GO:0043029; GO:0097202; GO:0071260; GO:0051607; GO:0097192; GO:0045087; GO:0048535; GO:0097049; GO:0070265; GO:0070236; GO:0060546; GO:2000454; GO:0043123; GO:0001916; GO:0042104; GO:0043065; GO:1902043; GO:0032729; GO:0032757; GO:0045862; GO:0045944; GO:0032760; GO:0060340; GO:0048536; GO:0048538\tP25446\t\tCD95 death-inducing signaling complex; T cell differentiation in thymus; T cell homeostasis; activation of cysteine-type endopeptidase activity; cellular response to mechanical stimulus; defense response to virus; extrinsic apoptotic signaling pathway in absence of ligand; innate immune response; lymph node development; motor neuron apoptotic process; necrotic cell death; negative regulation of activation-induced cell death of T cells; negative regulation of necroptosis; positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of T cell mediated cytotoxicity; positive regulation of activated T cell proliferation; positive regulation of apoptotic process; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of tumor necrosis factor production; positive regulation of type I interferon-mediated signaling pathway; spleen development; thymus development\treviewed\tIPR011029; IPR000488; IPR001875; IPR016729;\t\tProtein FADD (FAS-associated death domain protein) (FAS-associating death domain-containing protein) (Mediator of receptor induced toxicity)\tFadd Mort1\tMus musculus (Mouse)\t205\r",
        "\r\n",
        "Phel_clc_contig_63\tsp\tP49138\tMAPK2_MOUSE\t61.8\t89\t34\t0\t5240\t4974\t291\t379\t2E-27\t121\tP49138\tMAPK2_MOUSE\tGO:0070935; GO:0005524; GO:0031572; GO:0035924; GO:0005737; GO:0006954; GO:0048839; GO:0044351; GO:0005634; GO:0018105; GO:0004674; GO:0032675; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010\tP47811; Q64028; Q9QWH1\t\t3'-UTR-mediated mRNA stabilization; ATP binding; G2 DNA damage checkpoint; cellular response to vascular endothelial growth factor stimulus; cytoplasm; inflammatory response; inner ear development; macropinocytosis; nucleus; peptidyl-serine phosphorylation; protein serine/threonine kinase activity; regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; regulation of tumor necrosis factor production; response to cytokine stimulus; response to lipopolysaccharide; toll-like receptor signaling pathway; vascular endothelial growth factor receptor signaling pathway\treviewed\tIPR011009; IPR027442; IPR000719; IPR017441; IPR002290; IPR008271;\t\tMAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1)\tMapkapk2 Rps6kc1\tMus musculus (Mouse)\t386\r",
        "\r\n",
        "Phel_clc_contig_6334\tsp\tQ9Y5W3\tKLF2_HUMAN\t91.67\t84\t7\t0\t1438\t1187\t272\t355\t3E-46\t173\tQ9Y5W3\tKLF2_HUMAN\tGO:0000902; GO:0070301; GO:0071347; GO:0071499; GO:0071356; GO:0043249; GO:0001701; GO:0046872; GO:0035264; GO:0032715; GO:0005634; GO:0051247; GO:0036003; GO:0043565; GO:0003700; GO:0006351\t\t\tcell morphogenesis; cellular response to hydrogen peroxide; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; cellular response to laminar fluid shear stress; cellular response to tumor necrosis factor; erythrocyte maturation; in utero embryonic development; metal ion binding; multicellular organism growth; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; nucleus; positive regulation of protein metabolic process; positive regulation of transcription from RNA polymerase II promoter in response to stress; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent\treviewed\tIPR007087; IPR015880; IPR013087;\t\tKrueppel-like factor 2 (Lung krueppel-like factor)\tKLF2 LKLF\tHomo sapiens (Human)\t355\r",
        "\r\n",
        "Phel_clc_contig_6665\tsp\tQ9UDY8\tMALT1_HUMAN\t33.97\t368\t185\t11\t995\t3\t120\t466\t2E-40\t159\tQ9UDY8\tMALT1_HUMAN\tGO:0001923; GO:0032449; GO:0038095; GO:0042098; GO:0050852; GO:0007250; GO:0004197; GO:0005829; GO:0045087; GO:0043066; GO:0051168; GO:0005634; GO:0048471; GO:0005886; GO:0043123; GO:0051092; GO:0050870; GO:0002726; GO:0032743; GO:0031398; GO:0051259; GO:0006508; GO:0050856; GO:0009620; GO:0002237; GO:0004871; GO:0004842\tO95999; Q14790; Q9Y6K9; Q13501; Q9Y4K3; P0CG48\t\tB-1 B cell differentiation; CBM complex; Fc-epsilon receptor signaling pathway; T cell proliferation; T cell receptor signaling pathway; activation of NF-kappaB-inducing kinase activity; cysteine-type endopeptidase activity; cytosol; innate immune response; negative regulation of apoptotic process; nuclear export; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of NF-kappaB transcription factor activity; positive regulation of T cell activation; positive regulation of T cell cytokine production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 production; positive regulation of protein ubiquitination; protein oligomerization; proteolysis; regulation of T cell receptor signaling pathway; response to fungus; response to molecule of bacterial origin; signal transducer activity; ubiquitin-protein ligase activity\treviewed\tIPR011029; IPR007110; IPR013783; IPR003599; IPR003598; IPR011600; IPR001309;\t\tMucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)\tMALT1 MLT\tHomo sapiens (Human)\t824\r",
        "\r\n",
        "Phel_clc_contig_6698\tsp\tQ9JIL3\tILF3_RAT\t63.55\t107\t39\t0\t3\t323\t218\t324\t8E-36\t146\tQ9JIL3\tILF3_RAT\tGO:0003677; GO:0003723; GO:0005737; GO:0051607; GO:0017148; GO:0045071; GO:0005730; GO:0005634; GO:0006479; GO:0006468; GO:0030529; GO:0003700; GO:0006351\tQ63009\t\tDNA binding; RNA binding; cytoplasm; defense response to virus; negative regulation of translation; negative regulation of viral genome replication; nucleolus; nucleus; protein methylation; protein phosphorylation; ribonucleoprotein complex; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent\treviewed\tIPR014720; IPR006561;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K enhancer-binding factor 3\tIlf3\tRattus norvegicus (Rat)\t897\r",
        "\r\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Phel_clc_contig_6778\tsp\tQ00560\tIL6RB_MOUSE\t25.72\t311\t200\t11\t2354\t1473\t120\t416\t1E-08\t62.4\tQ00560\tIL6RB_MOUSE\tGO:0070110; GO:0030425; GO:0009897; GO:0005615; GO:0005977; GO:0038154; GO:0070106; GO:0004915; GO:0005896; GO:0004923; GO:0070104; GO:0043025; GO:0004924; GO:0005900; GO:0042102; GO:0048711; GO:0008284; GO:0045669; GO:0042511; GO:0042517; GO:0008593\tP97378; O35718\t\tciliary neurotrophic factor receptor complex; dendrite; external side of plasma membrane; extracellular space; glycogen metabolic process; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-11-mediated signaling pathway; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-27-mediated signaling pathway; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 receptor activity; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 receptor complex; leukemia inhibitory factor receptor activity; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6-mediated signaling pathway; neuronal cell body; oncostatin-M receptor activity; oncostatin-M receptor complex; positive regulation of T cell proliferation; positive regulation of astrocyte differentiation; positive regulation of cell proliferation; positive regulation of osteoblast differentiation; positive regulation of tyrosine phosphorylation of Stat1 protein; positive regulation of tyrosine phosphorylation of Stat3 protein; regulation of Notch signaling pathway\treviewed\tIPR003961; IPR003529; IPR013783; IPR010457; IPR015321;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)\tIl6st\tMus musculus (Mouse)\t917\r",
        "\r\n",
        "Phel_clc_contig_703\tsp\tP84173\tPHB_CHICK\t77.02\t248\t57\t0\t401\t1144\t24\t271\t9E-136\t412\tP84173\tPHB_CHICK\tGO:0006260; GO:0071354; GO:0016575; GO:0005887; GO:0005743; GO:0060766; GO:0030308; GO:0008285; GO:2000323; GO:0010944; GO:0005654; GO:0045893; GO:0050847; GO:0044212\tQ8AYS8\t\tDNA replication; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6; histone deacetylation; integral to plasma membrane; mitochondrial inner membrane; negative regulation of androgen receptor signaling pathway; negative regulation of cell growth; negative regulation of cell proliferation; negative regulation of glucocorticoid receptor signaling pathway; negative regulation of transcription by competitive promoter binding; nucleoplasm; positive regulation of transcription, DNA-dependent; progesterone receptor signaling pathway; transcription regulatory region DNA binding\treviewed\tIPR001107; IPR000163;\t\tProhibitin\tPHB\tGallus gallus (Chicken)\t272\r",
        "\r\n",
        "Phel_clc_contig_7490\tsp\tP50135\tHNMT_HUMAN\t33.63\t113\t69\t3\t1\t324\t64\t175\t7E-08\t58.9\tP50135\tHNMT_HUMAN\tGO:0007420; GO:0005737; GO:0046539; GO:0006972; GO:0043005; GO:0005634; GO:0007585; GO:0014075; GO:0042220; GO:0051384; GO:0070555; GO:0002347\t\t\tbrain development; cytoplasm; histamine N-methyltransferase activity; hyperosmotic response; neuron projection; nucleus; respiratory gaseous exchange; response to amine stimulus; response to cocaine; response to glucocorticoid stimulus; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; response to tumor cell\treviewed\tIPR016673;\t\tHistamine N-methyltransferase (HMT) (EC 2.1.1.8)\tHNMT\tHomo sapiens (Human)\t292\r",
        "\r\n",
        "Phel_clc_contig_750\tsp\tO08992\tSDCB1_MOUSE\t52.29\t306\t137\t5\t203\t1114\t1\t299\t4E-94\t310\tO08992\tSDCB1_MOUSE\tGO:0007265; GO:0070062; GO:0005137; GO:0005895; GO:0042470; GO:0042327\tP52795\t\tRas protein signal transduction; extracellular vesicular exosome; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-5 receptor binding; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-5 receptor complex; melanosome; positive regulation of phosphorylation\treviewed\tIPR001478;\t\tSyntenin-1 (Scaffold protein Pbp1) (Syndecan-binding protein 1)\tSdcbp\tMus musculus (Mouse)\t299\r",
        "\r\n",
        "Phel_clc_contig_7638\tsp\tB6ZK77\tIRL1B_DANRE\t21.53\t353\t214\t14\t2621\t1614\t179\t485\t7E-08\t60.5\tB6ZK77\tIRL1B_DANRE\tGO:0043679; GO:0005737; GO:0016021; GO:0016322; GO:0043025; GO:0005886; GO:0007165; GO:0050808\t\t\taxon terminus; cytoplasm; integral to membrane; neuron remodeling; neuronal cell body; plasma membrane; signal transduction; synapse organization\treviewed\tIPR007110; IPR013783; IPR003599; IPR003598; IPR015621; IPR000157;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-1 receptor accessory protein-like 1-B\til1rapl1b\tDanio rerio (Zebrafish) (Brachydanio rerio)\t700\r",
        "\r\n",
        "Phel_clc_contig_7666\tsp\tP98166\tVLDLR_RAT\t40.58\t138\t66\t6\t154\t564\t240\t362\t2E-13\t72.8\tP98166\tVLDLR_RAT\tGO:0045177; GO:0005509; GO:0009986; GO:0007166; GO:0042149; GO:0071456; GO:0032869; GO:0071347; GO:0071222; GO:0021987; GO:0008203; GO:0005905; GO:0007507; GO:0016021; GO:0006869; GO:0005634; GO:0048471; GO:0030296; GO:0042493; GO:0007584; GO:0034361; GO:0034447; GO:0030229\t\t\tapical part of cell; calcium ion binding; cell surface; cell surface receptor signaling pathway; cellular response to glucose starvation; cellular response to hypoxia; cellular response to insulin stimulus; cellular response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1; cellular response to lipopolysaccharide; cerebral cortex development; cholesterol metabolic process; coated pit; heart development; integral to membrane; lipid transport; nucleus; perinuclear region of cytoplasm; protein tyrosine kinase activator activity; response to drug; response to nutrient; very-low-density lipoprotein particle; very-low-density lipoprotein particle clearance; very-low-density lipoprotein particle receptor activity\treviewed\tIPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172;\t\tVery low-density lipoprotein receptor (VLDL receptor) (VLDL-R)\tVldlr\tRattus norvegicus (Rat)\t873\r",
        "\r\n",
        "Phel_clc_contig_8325\tsp\tQ8BJQ4\tTCAM2_MOUSE\t25.34\t146\t94\t5\t1509\t1105\t67\t208\t9E-08\t57\tQ8BJQ4\tTCAM2_MOUSE\tGO:0005794; GO:0035669; GO:0071222; GO:0005769; GO:0005783; GO:0006954; GO:0045087; GO:0005149; GO:0045323; GO:0005770; GO:0005543; GO:0071651; GO:0032729; GO:2000494; GO:0032755; GO:0034145; GO:0046982; GO:0043122; GO:0070671\t\t\tGolgi apparatus; TRAM-dependent toll-like receptor 4 signaling pathway; cellular response to lipopolysaccharide; early endosome; endoplasmic reticulum; inflammatory response; innate immune response; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor binding; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor complex; late endosome; phospholipid binding; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of interferon-gamma production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-18-mediated signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of toll-like receptor 4 signaling pathway; protein heterodimerization activity; regulation of I-kappaB kinase/NF-kappaB cascade; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-12\treviewed\tIPR000157;\t\tTIR domain-containing adapter molecule 2 (TICAM-2) (TRIF-related adapter molecule) (Toll/\u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-1 receptor domain-containing protein)\tTicam2 Tirp Tram\tMus musculus (Mouse)\t232\r",
        "\r\n",
        "Phel_clc_contig_841\tsp\tQ5VVH5\tIKBP1_HUMAN\t47.73\t88\t45\t1\t1554\t1294\t171\t258\t4E-14\t76.3\tQ5VVH5\tIKBP1_HUMAN\tGO:0007249; GO:0005737; GO:0005634; GO:0006355; GO:0006351\t\t\tI-kappaB kinase/NF-kappaB cascade; cytoplasm; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent\treviewed\tIPR007497;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1)\tIRAK1BP1\tHomo sapiens (Human)\t260\r",
        "\r\n",
        "Phel_clc_contig_8681\tsp\tQ60855\tRIPK1_MOUSE\t33.9\t295\t166\t8\t1086\t274\t19\t308\t2E-39\t154\tQ60855\tRIPK1_MOUSE\tGO:0005524; GO:0070231; GO:0060555; GO:0060554; GO:0044257; GO:0071356; GO:0031264; GO:0097191; GO:0005739; GO:0019048; GO:0043124; GO:2001237; GO:2001243; GO:0036289; GO:0043123; GO:0046330; GO:0051092; GO:0043065; GO:2001238; GO:0032757; GO:0045651; GO:0001934; GO:0045944; GO:0051347; GO:0032760; GO:0051291; GO:0051260; GO:0004674; GO:0043235; GO:0070926; GO:2000377; GO:0097342; GO:1901026\tO43464; Q9QZL0; P25118\t\tATP binding; T cell apoptotic process; activation of necroptosis by extracellular signals; activation of necroptosis of activated-T cells; cellular protein catabolic process; cellular response to tumor necrosis factor; death-inducing signaling complex; extrinsic apoptotic signaling pathway; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of extrinsic apoptotic signaling pathway; negative regulation of intrinsic apoptotic signaling pathway; peptidyl-serine autophosphorylation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of NF-kappaB transcription factor activity; positive regulation of apoptotic process; positive regulation of extrinsic apoptotic signaling pathway; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-8 production; positive regulation of macrophage differentiation; positive regulation of protein phosphorylation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transferase activity; positive regulation of tumor necrosis factor production; protein heterooligomerization; protein homooligomerization; protein serine/threonine kinase activity; receptor complex; regulation of ATP:ADP antiporter activity; regulation of reactive oxygen species metabolic process; ripoptosome; ripoptosome assembly involved in necroptosis\treviewed\tIPR011029; IPR000488; IPR011009; IPR000719; IPR025735; IPR001245; IPR008271;\t\tReceptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) (Serine/threonine-protein kinase RIP)\tRipk1 Rinp Rip\tMus musculus (Mouse)\t656\r",
        "\r\n",
        "Phel_clc_contig_9097\tsp\tA2VDU3\tM3K7_BOVIN\t72.69\t271\t66\t2\t1823\t1032\t55\t324\t7E-143\t436\tA2VDU3\tM3K7_BOVIN\tGO:0005524; GO:0005671; GO:0007252; GO:0008385; GO:0007254; GO:0004709; GO:0000187; GO:0007250; GO:0006915; GO:0043966; GO:0000287; GO:0005886; GO:0043123; GO:0043507; GO:0002726; GO:0032743; GO:0006355; GO:0006351\t\t\tATP binding; Ada2/Gcn5/Ada3 transcription activator complex; I-kappaB phosphorylation; IkappaB kinase complex; JNK cascade; MAP kinase kinase kinase activity; activation of MAPK activity; activation of NF-kappaB-inducing kinase activity; apoptotic process; histone H3 acetylation; magnesium ion binding; plasma membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JUN kinase activity; positive regulation of T cell cytokine production; positive regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-2 production; regulation of transcription, DNA-dependent; transcription, DNA-dependent\treviewed\tIPR011009; IPR017421; IPR000719; IPR017441; IPR001245; IPR008271;\t\tMitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25)\tMAP3K7\tBos taurus (Bovine)\t579\r",
        "\r\n",
        "Phel_clc_contig_9338\tsp\tQ01705\tNOTC1_MOUSE\t38.87\t602\t282\t19\t5719\t4025\t1666\t2218\t3E-70\t266\tQ01705\tNOTC1_MOUSE\tGO:0000139; GO:0002193; GO:0003270; GO:0001190; GO:0042640; GO:0003180; GO:1902263; GO:0060842; GO:0003162; GO:0003181; GO:0009912; GO:0007409; GO:0048754; GO:0005509; GO:0003214; GO:0060038; GO:0003213; GO:0003219; GO:0060411; GO:0060948; GO:0001708; GO:0003273; GO:0009986; GO:0071372; GO:0035924; GO:0031490; GO:0072044; GO:0007386; GO:0001047; GO:0060982; GO:0003169; GO:0005856; GO:0005829; GO:0072017; GO:0035116; GO:0060956; GO:0003160; GO:0007492; GO:0005789; GO:0004857; GO:0003198; GO:0005576; GO:0030900; GO:0007440; GO:0010001; GO:0072144; GO:0003241; GO:0031069; GO:0001947; GO:0006959; GO:0001701; GO:0002437; GO:0005887; GO:0072602; GO:0030216; GO:0030027; GO:0070986; GO:0001889; GO:0030324; GO:0003192; GO:0030514; GO:2000811; GO:0045955; GO:0090090; GO:0060548; GO:0090051; GO:0010812; GO:2001027; GO:0060253; GO:0045662; GO:0010832; GO:0048715; GO:0030279; GO:0045668; GO:0046533; GO:2000974; GO:2000737; GO:0000122; GO:0021915; GO:0097150; GO:0005654; GO:0002051; GO:0003344; GO:0030513; GO:0046427; GO:0043065; GO:0048711; GO:0060045; GO:0030335; GO:1901189; GO:0050679; GO:0010718; GO:0045618; GO:0061419; GO:0007221; GO:0060740; GO:0003184; GO:0004872; GO:0061344; GO:0060768; GO:1901201; GO:0014807; GO:0003256; GO:0032495; GO:0001726; GO:0060528; GO:0043565; GO:0003700; GO:0035914; GO:0048103; GO:0002040; GO:0035148; GO:0060979; GO:0060843; GO:0060412; GO:0003222\tQ06330; P31266; P28159\t\tGolgi membrane; MAML1-RBP-Jkappa- ICN1 complex; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; anagen; aortic valve morphogenesis; apoptotic process involved in embryonic digit morphogenesis; arterial endothelial cell differentiation; atrioventricular node development; atrioventricular valve morphogenesis; auditory receptor cell fate commitment; axonogenesis; branching morphogenesis of an epithelial tube; calcium ion binding; cardiac left ventricle morphogenesis; cardiac muscle cell proliferation; cardiac right atrium morphogenesis; cardiac right ventricle formation; cardiac septum morphogenesis; cardiac vascular smooth muscle cell development; cell fate specification; cell migration involved in endocardial cushion formation; cell surface; cellular response to follicle-stimulating hormone stimulus; cellular response to vascular endothelial growth factor stimulus; chromatin DNA binding; collecting duct development; compartment pattern specification; core promoter binding; coronary artery morphogenesis; coronary vein morphogenesis; cytoskeleton; cytosol; distal tubule development; embryonic hindlimb morphogenesis; endocardial cell differentiation; endocardium morphogenesis; endoderm development; endoplasmic reticulum membrane; enzyme inhibitor activity; epithelial to mesenchymal transition involved in endocardial cushion formation; extracellular region; forebrain development; foregut morphogenesis; glial cell differentiation; glomerular mesangial cell development; growth involved in heart morphogenesis; hair follicle morphogenesis; heart looping; humoral immune response; in utero embryonic development; inflammatory response to antigenic stimulus; integral to plasma membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-4 secretion; keratinocyte differentiation; lamellipodium; left/right axis specification; liver development; lung development; mitral valve formation; negative regulation of BMP signaling pathway; negative regulation of anoikis; negative regulation of calcium ion-dependent exocytosis; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell death; negative regulation of cell migration involved in sprouting angiogenesis; negative regulation of cell-substrate adhesion; negative regulation of endothelial cell chemotaxis; negative regulation of glial cell proliferation; negative regulation of myoblast differentiation; negative regulation of myotube differentiation; negative regulation of oligodendrocyte differentiation; negative regulation of ossification; negative regulation of osteoblast differentiation; negative regulation of photoreceptor cell differentiation; negative regulation of pro-B cell differentiation; negative regulation of stem cell differentiation; negative regulation of transcription from RNA polymerase II promoter; neural tube development; neuronal stem cell maintenance; nucleoplasm; osteoblast fate commitment; pericardium morphogenesis; positive regulation of BMP signaling pathway; positive regulation of JAK-STAT cascade; positive regulation of apoptotic process; positive regulation of astrocyte differentiation; positive regulation of cardiac muscle cell proliferation; positive regulation of cell migration; positive regulation of ephrin receptor signaling pathway; positive regulation of epithelial cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of keratinocyte differentiation; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; positive regulation of transcription of Notch receptor target; prostate gland epithelium morphogenesis; pulmonary valve morphogenesis; receptor activity; regulation of cell adhesion involved in heart morphogenesis; regulation of epithelial cell proliferation involved in prostate gland development; regulation of extracellular matrix assembly; regulation of somitogenesis; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; response to muramyl dipeptide; ruffle; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; somatic stem cell division; sprouting angiogenesis; tube formation; vasculogenesis involved in coronary vascular morphogenesis; venous endothelial cell differentiation; ventricular septum morphogenesis; ventricular trabecula myocardium morphogenesis\treviewed\tIPR002110; IPR020683; IPR024600; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR008297; IPR022362; IPR000800; IPR010660; IPR011656;\t\tNeurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation; Notch 1 intracellular domain (NICD)]\tNotch1 Motch\tMus musculus (Mouse)\t2531\r",
        "\r\n",
        "Phel_clc_contig_961\tsp\tP40190\tIL6RB_RAT\t25.53\t423\t258\t17\t4639\t3440\t31\t419\t1E-17\t93.6\tP40190\tIL6RB_RAT\tGO:0016021; GO:0019981; GO:0004915; GO:0032809; GO:0014911; GO:0046982; GO:0051481; GO:0046883; GO:0007584; GO:0006642\t\t\tintegral to membrane; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 binding; \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 receptor activity; neuronal cell body membrane; positive regulation of smooth muscle cell migration; protein heterodimerization activity; reduction of cytosolic calcium ion concentration; regulation of hormone secretion; response to nutrient; triglyceride mobilization\treviewed\tIPR003961; IPR003529; IPR013783; IPR010457;\t\t\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)\tIl6st\tRattus norvegicus (Rat)\t918\r",
        "\r\n",
        "Phel_clc_contig_9761\tsp\tQ7ZX03\tFOXK2_XENLA\t58.22\t383\t133\t6\t136\t1230\t12\t385\t4E-131\t409\tQ7ZX03\tFOXK2_XENLA\tGO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351\t\t\tmagnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent\treviewed\tIPR000253; IPR008984; IPR001766; IPR018122; IPR011991;\t\tForkhead box protein K2 (FoxK2) (\u001b[01;31m\u001b[KInterleukin\u001b[m\u001b[K enhancer-binding factor 1) (ILF1) (xFoxK1)\tfoxk2 foxk1 ilf1\tXenopus laevis (African clawed frog)\t642\r",
        "\r\n",
        "Phel_clc_contig_9772\tsp\tO60488\tACSL4_HUMAN\t47.97\t715\t353\t8\t2324\t204\t8\t711\t0\t642\tO60488\tACSL4_HUMAN\tGO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0005811; GO:0004467; GO:0035338; GO:0005741; GO:0032307; GO:0043025; GO:0005778; GO:0030307; GO:0070672; GO:0007584; GO:0019432; GO:0031957\t\t\tATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; long-chain fatty-acyl-CoA biosynthetic process; mitochondrial outer membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisomal membrane; positive regulation of cell growth; response to \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-15; response to nutrient; triglyceride biosynthetic process; very long-chain fatty acid-CoA ligase activity\treviewed\tIPR020845; IPR000873;\t\tLong-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4)\tACSL4 ACS4 FACL4 LACS4\tHomo sapiens (Human)\t711\r",
        "\r\n",
        "Phel_clc_contig_9837\tsp\tP17439\tGLCM_MOUSE\t48.68\t76\t38\t1\t1185\t958\t438\t512\t7E-14\t76.6\tP17439\tGLCM_MOUSE\tGO:0005975; GO:0071356; GO:0046513; GO:0004348; GO:0006680; GO:0043202; GO:0005765; GO:0043407; GO:0032715; GO:0035307; GO:0046512; GO:0023021\tQ14108; O35114\t\tcarbohydrate metabolic process; cellular response to tumor necrosis factor; ceramide biosynthetic process; glucosylceramidase activity; glucosylceramide catabolic process; lysosomal lumen; lysosomal membrane; negative regulation of MAP kinase activity; negative regulation of \u001b[01;31m\u001b[Kinterleukin\u001b[m\u001b[K-6 production; positive regulation of protein dephosphorylation; sphingosine biosynthetic process; termination of signal transduction\treviewed\tIPR013780; IPR001139; IPR013781; IPR017853;\t\tGlucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase)\tGba\tMus musculus (Mouse)\t515\r",
        "\r\n"
       ]
      }
     ],
     "prompt_number": 65
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": []
    }
   ],
   "metadata": {}
  }
 ]
}